This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other metabolic disorders
E4_METABO
metabolic disease: A congenital disorder (due to inherited enzyme abnormality) or acquired (due to failure of a metabolically important organ) disorder resulting from an abnormal metabolic process.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
459 |
4. Check minimum number of eventsNone |
459 |
5. Include endpoints |
5707 |
6. Filter based on genotype QC (FinnGen only) |
5707 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E70-E90
- Name in latin
- Aliae morbositates metabolicae
Similar endpoints
↥List of similar endpoints to
Other metabolic disorders
based on the number of shared cases.
Similar with more cases:
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5707 | 4515 | 1192 |
| Unadjusted period prevalence (%) | 1.33 | 1.54 | 0.53 |
| Median age at first event (years) | 52.28 | 51.34 | 55.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5037
- Matched controls
- 50368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A11CC03
ATC
alfacalcidol; systemic
27.6
323.0
465
185
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
5025.0
323.0
468
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
323.0
2404
10846
BAA60
NOMESCO Finland
Total thyroidectomy
60.5
323.0
1562
371
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
50.1
323.0
734
171
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.3
323.0
867
1226
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
26.6
323.0
965
445
121
Kela drug reimbursment
Severe hypofunction of sexual glands
35.4
323.0
860
291
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
42.4
323.0
603
161
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
34.0
323.0
1374
549
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
346.8
323.0
2007
96
H03BB01
ATC
carbimazole; oral
30.4
323.0
1634
783
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
1478.3
323.0
1145
10
H03AA01
ATC
levothyroxine sodium; systemic
15.8
323.0
3755
7864
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
54.9
323.0
464
93
104
Kela drug reimbursment
Thyroid insufficiency
21.2
323.0
2176
1748
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
781.3
302.3
295
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
22.8
263.4
389
184
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
8.1
261.5
626
862
106
Kela drug reimbursment
Hypoparathyroidism
219.1
243.0
250
12
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
+∞
232.1
221
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
16.3
218.3
363
239
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
54.5
212.0
254
49
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.7
208.7
1051
3329
E83.51
ICD-10 Finland
Hypocalcemia
184.3
203.6
212
12
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
58.9
199.5
236
42
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
8.7
165.2
374
460
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
20.4
159.2
243
125
4CJ01
NOMESCO Finland
NA
107.9
153.0
167
16
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
151.9
1623
8186
C07AA05
ATC
propranolol; systemic
2.6
144.7
1350
6296
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
12.4
142.2
265
225
A11CC02
ATC
dihydrotachysterol; oral
112.7
140.9
153
14
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
10.7
134.1
269
265
A12AA04
ATC
calcium carbonate; oral
17.3
132.0
213
128
ZX114
NOMESCO Finland
Intramuscular
11.0
130.8
258
246
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
126.4
1362
6778
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
126.3
2090
12674
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
65.3
125.6
146
23
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
7.2
124.1
317
467
C07AB07
ATC
bisoprolol; oral
2.1
123.8
2144
13218
H02AB09
ATC
hydrocortisone; systemic
8.2
123.8
289
371
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
157.5
116.8
123
8
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
10.4
114.6
232
232
T86
ICPC
Hypothyroidism/myxoedema
4.8
114.4
406
897
E03.89
ICD-10 Finland
Other specified hypothyroidism
5.1
108.8
367
767
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.3
108.3
608
2012
E89.4
ICD-10 Finland
Postprocedural ovarian failure
350.9
103.5
104
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
95.5
101.4
112
12
127
Kela drug reimbursment
Transplant complication
12.6
99.7
183
150
ZXA10
NOMESCO Finland
Bilateral
2.3
96.6
1068
5277
E03
ICD-10 Finland
Other hypothyroidism
3.5
94.0
487
1510
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
8.6
93.6
210
252
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
28.0
89.2
123
45
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.5
87.1
270
510
WX402
NOMESCO Finland
General anaesthesia
2.3
85.7
974
4842
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
83.0
1031
5328
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
+∞
82.5
79
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
19.5
82.0
126
66
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
44.7
81.7
101
23
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.0
80.6
275
579
N02BE01
ATC
paracetamol; systemic, rectal
2.1
79.8
4292
37065
E88.2
ICD-10 Finland
Lipomatosis, not elsewhere classified
97.2
78.1
86
9
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
77.5
512
1878
H02AB06
ATC
prednisolone; systemic
1.7
73.6
2286
16310
2440A
ICD-9 Finland
Acquired hypothyroidism, Postsurgical hypothyroidism
+∞
72.0
69
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
71.4
625
2703
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
29.1
71.3
97
34
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
37.0
70.9
91
25
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
22.1
69.3
102
47
T85
ICPC
Hyperthyroidism/thyrotoxicosis
14.7
69.2
118
82
C03CA01
ATC
furosemide; systemic
2.0
68.2
1054
5900
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
8.8
67.0
148
173
N80.1
ICD-10 Finland
Endometriosis of ovary
4.1
66.9
278
711
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
21.0
66.2
99
48
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
39.7
64.9
82
21
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
64.1
1344
8372
H062, E050
ICD-10 Finland
NA
38.7
63.0
80
21
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.0
61.9
261
676
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
615.5
61.9
61
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
61.8
198
388
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
61.7
1088
6369
A02BC02
ATC
pantoprazole; systemic
1.6
61.4
3092
24749
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
6.3
61.1
168
273
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
61.0
2030
14506
E20.8
ICD-10 Finland
Other hypoparathyroidism
595.0
59.8
59
*
E87.6
ICD-10 Finland
Hypokalaemia
11.0
59.1
115
107
E83.50
ICD-10 Finland
Hypercalcemia
21.8
58.4
86
40
XW000
NOMESCO Finland
Bone marrow biopsy
4.0
57.6
240
615
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
57.0
337
1140
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
564.3
56.7
56
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
56.2
1905
13584
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.7
56.1
407
1571
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
79.8
56.0
63
8
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
9.9
55.7
114
117
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
15.6
55.4
92
60
E89.9
ICD-10 Finland
Postprocedural endocrine and metabolic disorder, unspecified
+∞
55.3
53
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
54.3
2239
16770
L04AD01
ATC
ciclosporin; systemic
5.9
53.9
157
275
R4110
NOMESCO Finland
Physiotherapy
1.8
53.2
1240
7907
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
18.5
52.7
82
45
T71
ICPC
Malignant neoplasm thyroid
37.7
52.6
67
18
LCD00
NOMESCO Finland
Hysterectomy
2.9
52.4
339
1218
ZX120
NOMESCO Finland
Intravenous
2.4
52.3
488
2164
101
Kela drug reimbursment
Anterior pituitary hypofunction
14.9
52.1
88
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
51.5
620
3096
E88.8
ICD-10 Finland
Other specified metabolic disorders
+∞
51.1
49
*
C08CA01
ATC
amlodipine; oral
1.7
50.8
1340
8847
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
50.2
281
914
B01AB05
ATC
enoxaparin; parenteral
1.7
50.1
1380
9219
WW200
NOMESCO Finland
Immunization
4.3
49.8
192
458
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
49.6
460
2028
R06.0
ICD-10 Finland
Dyspnoea
1.8
49.3
1062
6582
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
3.4
48.8
249
756
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
78.1
48.0
54
7
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
47.9
2386
18503
E88.9
ICD-10 Finland
Metabolic disorder, unspecified
472.1
47.4
47
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
4.8
46.8
161
342
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
9.0
46.4
100
113
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
46.3
654
3482
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
17.6
46.2
73
42
Z51.88
ICD-10 Finland
Other specified medical care
5.5
46.0
140
259
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
45.9
702
3852
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
85.9
45.9
51
6
WX704
NOMESCO Finland
Intubation
2.5
45.4
392
1666
R50.9
ICD-10 Finland
Fever, unspecified
2.0
44.7
640
3425
C07AB02
ATC
metoprolol; systemic
1.8
44.4
813
4756
A05AA02
ATC
ursodeoxycholic acid; oral
4.9
44.4
150
313
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
44.3
1563
11079
A10AE04
ATC
insulin glargine; parenteral
2.5
44.1
365
1515
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
44.1
812
4759
E21.0
ICD-10 Finland
Primary hyperparathyroidism
5.8
43.8
128
226
A12AA06
ATC
calcium lactate gluconate; oral
57.2
43.4
51
9
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
42.8
840
5023
E23.00
ICD-10 Finland
Panhypopituitarism
20.2
42.6
64
32
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.3
42.2
223
696
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
42.1
753
4362
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
46.8
41.9
51
11
J01DB01
ATC
cefalexin; oral
1.6
41.7
3947
34933
E88.1
ICD-10 Finland
Lipodystrophy, not elsewhere classified
+∞
41.7
40
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
7.1
41.4
104
150
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
41.4
764
4473
UJF32
NOMESCO Finland
Coloscopy
1.7
41.3
1113
7319
WZC30
NOMESCO Finland
Teaching
2.0
41.2
614
3328
N03AX16
ATC
pregabalin; oral
1.7
40.6
1063
6927
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
40.5
1700
12509
SPAT1262
SPAT
Handing over of treatment supplies
1.9
40.3
709
4079
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
39.9
516
2644
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.6
39.5
305
1217
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
5.5
39.4
120
223
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.1
39.2
110
185
C10AA05
ATC
atorvastatin; oral
1.6
39.1
1260
8669
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
39.1
214
685
E86
ICD-10 Finland
Volume depletion
22.6
38.7
56
25
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
38.5
333
1411
A02BC05
ATC
esomeprazole; systemic
1.5
37.8
1879
14297
ZXA00
NOMESCO Finland
Right side
1.6
37.6
1170
7968
A02BC01
ATC
omeprazole; systemic
1.6
36.7
1218
8424
AA1AD
NOMESCO Finland
CT of head and brain
1.7
36.5
886
5632
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
5.5
36.2
110
204
P01AB01
ATC
metronidazole; oral, rectal
1.5
36.1
1958
15134
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.7
35.6
256
979
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
28.5
35.5
48
17
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
8.6
35.4
78
92
WW500
NOMESCO Finland
Blood transfusion
3.1
35.2
203
675
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
34.7
905
5860
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
34.6
848
5393
H01AC01
ATC
somatropin; parenteral
30.2
33.8
45
15
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
33.7
293
1245
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
33.2
489
2629
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
17.5
33.1
52
30
N05CF01
ATC
zopiclone; oral
1.5
33.0
1392
10140
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
32.9
995
6695
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.8
32.9
112
237
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
3.0
32.8
202
702
N02AA05
ATC
oxycodone; systemic
1.9
32.6
555
3140
G47.3
ICD-10 Finland
Sleep apnoea
1.7
32.6
829
5321
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
32.6
604
3520
N03AX12
ATC
gabapentin; oral
1.7
32.4
692
4219
JN4BD
NOMESCO Finland
Extensive body CT
2.0
32.3
455
2404
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
32.3
1040
7104
J01MA12
ATC
levofloxacin; systemic
1.7
32.2
743
4638
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
7.3
32.1
78
108
L03AA02
ATC
filgrastim; parenteral
3.4
32.0
158
469
R53
ICD-10 Finland
Malaise and fatigue
1.6
31.9
878
5755
105
Kela drug reimbursment
Adrenal cortical hypofunction
17.4
31.8
50
29
L04AA06
ATC
mycophenolic acid; systemic
5.0
31.3
103
210
H02AB04
ATC
methylprednisolone; systemic
1.7
31.0
684
4209
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
314.7
30.9
31
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
30.5
465
2530
WX110
NOMESCO Finland
Local anesthesy
1.4
30.5
3250
28245
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
30.4
736
4651
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
30.4
489
2710
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
30.4
228
893
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
30.2
232
924
2506
FHL
Thyroidectomy
16.7
30.1
48
29
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
30.0
590
3502
205
Kela drug reimbursment
Chronic hypertension
1.6
30.0
899
6017
F64.0
ICD-10 Finland
Transsexualism
41.3
29.9
37
9
J01MA02
ATC
ciprofloxacin; systemic
1.5
29.8
1595
12159
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
5.8
29.6
85
148
T90
ICPC
Diabetes non-insulin dependent
1.6
29.5
773
4989
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
8.2
29.4
66
81
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
30.2
29.4
39
13
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
29.3
1474
11089
C03DA01
ATC
spironolactone; oral
2.1
29.3
367
1847
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.4
29.3
148
448
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
29.3
176
603
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
29.2
653
4027
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
13.6
28.9
50
37
J01FF01
ATC
clindamycin; systemic
1.5
28.3
1163
8371
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.8
28.3
97
207
L28
ICPC
Limited function/disability (L)
1.7
28.3
595
3601
H02AA02
ATC
fludrocortisone; oral
8.1
28.2
64
80
E8901, C7391
ICD-10 Finland
NA
+∞
28.1
27
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
28.1
339
1682
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
28.1
339
1683
WX892
NOMESCO Finland
Monitored bed care
2.2
28.0
287
1324
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
27.5
188
699
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
10.7
27.4
53
50
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
47.4
27.4
33
7
R42
ICD-10 Finland
Dizziness and giddiness
1.6
27.3
864
5847
R03AC02
ATC
salbutamol; inhalant
1.4
27.3
2445
20396
C10AA01
ATC
simvastatin; oral
1.5
27.3
1343
10030
S18
ICPC
Laceration/cut
1.4
27.2
1715
13433
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
5.7
27.2
79
140
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
27.2
212
850
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
9.1
27.1
57
63
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
26.9
376
1979
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
41.5
26.7
33
8
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.4
26.7
132
393
WX002
NOMESCO Finland
Sedation and analgesia
1.6
26.7
827
5562
R11
ICD-10 Finland
Nausea and vomiting
2.0
26.5
344
1756
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
26.3
332
1675
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.7
26.2
188
718
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
10.1
26.1
52
52
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
26.1
1036
7381
XF402
NOMESCO Finland
ECG with work load test
1.9
25.9
380
2033
C10AA07
ATC
rosuvastatin; oral
1.6
25.8
825
5586
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
25.8
310
1533
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
17.5
25.7
40
23
N05BA04
ATC
oxazepam; oral
1.5
25.6
1097
7942
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
5.6
25.5
75
135
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
15.1
25.5
42
28
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
10.3
25.4
50
49
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.1
25.0
284
1372
R02
ICPC
Shortness of breath/dyspnoea
1.8
24.9
480
2823
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
14.1
24.8
42
30
A04AA01
ATC
ondansetron; systemic, rectal
2.0
24.7
316
1604
E05.89
ICD-10 Finland
Other thyrotoxicosis
10.5
24.7
48
46
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
24.7
780
5264
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.5
24.6
88
197
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
24.4
276
1330
R51.80
ICD-10 Finland
Headache
1.6
24.4
670
4363
ZXA05
NOMESCO Finland
Left side
1.5
24.4
1029
7417
XF404
NOMESCO Finland
Ambulatory ECG
2.0
24.1
336
1766
Z71.8
ICD-10 Finland
Other specified counselling
1.5
23.9
1051
7630
H03BA02
ATC
propylthiouracil; oral
25.5
23.9
33
13
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
23.7
2018
16540
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
23.7
831
5743
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
15.1
23.7
39
26
B01AA03
ATC
warfarin; systemic
1.7
23.6
574
3615
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
23.5
390
2181
R13
ICD-10 Finland
Dysphagia
2.1
23.5
267
1289
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
4.9
23.5
78
162
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
23.5
199
836
M04AA01
ATC
allopurinol; systemic
1.9
23.4
349
1880
WX720
NOMESCO Finland
Own respiration
2.6
23.4
171
661
E66.8
ICD-10 Finland
Other obesity
2.2
23.4
252
1191
H53.2
ICD-10 Finland
Diplopia
2.9
23.3
148
528
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
15.3
23.2
38
25
J01AA02
ATC
doxycycline; systemic
1.4
23.1
3645
32944
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
23.1
344
1852
A10AE05
ATC
insulin detemir; parenteral
2.4
23.1
208
903
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
23.0
261
1259
H02AB07
ATC
prednisone; oral
1.6
23.0
609
3922
A04
ICPC
Weakness/tiredness general
1.7
23.0
524
3238
N80.5
ICD-10 Finland
Endometriosis of intestine
6.8
23.0
58
86
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
22.9
457
2714
R03BB04
ATC
tiotropium bromide; inhalant
1.9
22.9
339
1822
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
16.5
22.7
36
22
B01AC04
ATC
clopidogrel; oral
1.8
22.6
376
2104
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
22.6
344
1867
C09CA01
ATC
losartan; oral
1.5
22.5
877
6202
C73.94
ICD-10 Finland
Medullary thyroid carcinoma (thyroid)
32.4
22.4
29
9
A02BC03
ATC
lansoprazole; oral
1.4
22.3
1222
9249
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
22.3
216
970
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
22.2
311
1635
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
16.8
22.2
35
21
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.1
21.9
125
413
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
29.1
21.8
29
10
T89
ICPC
Diabetes insulin dependent
2.6
21.7
161
628
B01AB10
ATC
tinzaparin; parenteral
2.0
21.7
287
1477
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
25.1
21.7
30
12
ZX108
NOMESCO Finland
Inhalation
7.3
21.7
52
72
A28
ICPC
Limited function/disability NOS
1.7
21.6
475
2905
N06AX11
ATC
mirtazapine; oral
1.4
21.6
1365
10593
J02AC01
ATC
fluconazole; systemic
1.3
21.6
2081
17318
Z31.5
ICD-10 Finland
Genetic counselling
2.0
21.5
268
1348
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.8
21.4
72
152
E05.5
ICD-10 Finland
Thyroid crisis or storm
26.5
21.3
29
11
102
Kela drug reimbursment
Diabetes insipidus
17.5
21.3
33
19
R06AE07
ATC
cetirizine; oral
1.3
21.3
2047
17017
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
21.2
1022
7537
C09AA05
ATC
ramipril; oral
1.5
21.1
755
5227
J01FA10
ATC
azithromycin; systemic
1.3
21.0
2754
23967
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
20.9
708
4839
JN5SN
NOMESCO Finland
NA
60.2
20.9
24
*
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
+∞
20.8
20
*
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
20.8
1592
12746
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
5.0
20.7
67
136
A07AA02
ATC
nystatin; oral
2.0
20.7
273
1405
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
20.6
405
2393
R03DC03
ATC
montelukast; oral
1.5
20.6
743
5153
A06AD11
ATC
lactulose; oral
1.7
20.5
481
2993
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
20.5
569
3706
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
20.5
273
1408
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
20.5
307
1654
R03BA01
ATC
beclometasone; inhalant
1.6
20.5
622
4142
L04AA01
ATC
[U] ciclosporin; systemic
3.8
20.4
87
231
N18.8
ICD-10 Finland
Other chronic renal failure
3.8
20.4
87
231
R4190
NOMESCO Finland
Nutritional therapy
2.6
20.4
157
627
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.6
20.4
93
262
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
20.4
596
3934
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
20.3
612
4067
J01FA06
ATC
roxithromycin; oral
1.3
20.3
1804
14781
C10AX09
ATC
ezetimibe; oral
1.9
20.2
293
1560
E87.5
ICD-10 Finland
Hyperkalaemia
10.9
20.1
38
35
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
6.7
20.1
51
77
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.6
20.0
58
104
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
2.7
19.9
143
549
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
19.9
444
2721
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
19.8
559
3652
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
19.8
510
3256
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
19.8
433
2641
A10BA02
ATC
metformin; oral
1.5
19.8
874
6326
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
19.7
1570
12626
N06AX21
ATC
duloxetine; oral
1.6
19.7
487
3072
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.8
19.7
56
98
TK800
NOMESCO Finland
Hemodialysis
3.9
19.7
81
209
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
5.1
19.6
62
123
A09AA02
ATC
multienzymes (lipase, protease etc.)
3.5
19.6
91
260
A02BA02
ATC
ranitidine; systemic
1.5
19.6
765
5393
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
19.5
210
991
AN1
HP
Coronary angiography
1.9
19.5
280
1487
JAH01
NOMESCO Finland
Laparoscopy
2.1
19.4
232
1144
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
19.4
510
3274
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
19.3
345
1978
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
15.6
19.2
31
20
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.7
19.2
84
229
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
19.2
210
1000
J01DA01
ATC
[U] cefalexin; systemic
1.3
19.2
2885
25452
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
19.1
271
1434
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
19.0
288
1559
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
19.0
2293
19591
N06AX16
ATC
venlafaxine; oral
1.5
19.0
622
4212
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.1
18.9
104
338
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
18.9
423
2598
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
18.9
372
2198
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
18.9
396
2387
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
18.9
920
6785
JAH00
NOMESCO Finland
Laparotomy
2.8
18.8
120
430
C08CA02
ATC
felodipine; oral
1.9
18.8
300
1656
Z01.7
ICD-10 Finland
Laboratory examination
1.7
18.8
449
2809
2504
FHL
Unilateral resection or enucleation
5.1
18.7
59
117
C08CA13
ATC
lercanidipine; oral
1.7
18.6
441
2748
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.7
18.6
410
2503
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
23.7
18.6
26
11
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
38.5
18.5
23
6
J01FA09
ATC
clarithromycin; systemic
1.4
18.5
1438
11496
SPAT1153
SPAT
Removal of sutures
1.4
18.5
1269
9941
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
18.5
1711
14052
E06.3
ICD-10 Finland
Autoimmune thyroiditis
5.0
18.4
59
119
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
18.4
368
2187
J01CA04
ATC
amoxicillin; systemic
1.4
18.4
3817
35174
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.0
18.3
228
1145
M79.6
ICD-10 Finland
Pain in limb
1.3
18.2
1512
12199
UKC02
NOMESCO Finland
Cystoscopy
1.6
18.2
490
3166
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.5
18.1
84
241
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
18.0
256
1356
G03DC03
ATC
lynestrenol; oral
2.5
17.9
144
591
128
Kela drug reimbursment
Cancers of female genital organs
3.0
17.8
102
339
BBA20
NOMESCO Finland
Exploration of parathyroid gland
8.7
17.8
38
44
R03BA02
ATC
budesonide; inhalant
1.5
17.8
751
5373
N80.8
ICD-10 Finland
Other endometriosis
6.7
17.8
45
68
JN4AD
NOMESCO Finland
Body CT examination
1.9
17.7
266
1437
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
2.6
17.7
134
532
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
4.3
17.7
65
152
R01AD09
ATC
mometasone; nasal
1.3
17.6
2073
17580
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
8.9
17.6
37
42
H50.2
ICD-10 Finland
Vertical strabismus
5.3
17.3
52
98
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
17.3
506
3333
Z94.2
ICD-10 Finland
Lung transplant status
20.9
17.3
25
12
J01MA14
ATC
moxifloxacin; systemic
1.7
17.2
336
1979
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.0
17.1
55
112
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
6.1
17.0
46
76
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
17.0
1262
9990
301
Kela drug reimbursment
Growth hormone
50.2
17.0
20
*
E04.8
ICD-10 Finland
Other specified nontoxic goitre
6.4
17.0
44
69
TFP20
NOMESCO Finland
Cardiodefibrillation
2.0
16.9
216
1100
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
16.8
273
1514
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.1
16.8
30
25
SPAT1263
SPAT
Sampling
1.3
16.7
1784
14892
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
16.6
317
1853
R49.08
ICD-10 Finland
Other specified dysphonia
2.7
16.6
117
447
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
16.6
452
2925
L17
ICPC
Foot/toe symptom/complaint
1.4
16.5
993
7584
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
27.6
16.5
22
8
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.2
16.4
50
96
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
16.4
272
1523
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
16.3
975
7433
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.7
16.3
111
416
24209
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffuse NUD
14.3
16.3
27
19
RD210
NOMESCO Finland
NA
3.2
16.2
86
274
CA1AD
NOMESCO Finland
Orbita CT
11.2
16.2
30
27
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.0
16.2
223
1167
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
16.2
231
1225
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.5
16.0
129
531
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
24.5
16.0
22
9
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
15.8
1160
9147
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.7
15.8
45
80
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.7
15.8
111
424
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
15.8
342
2081
R01AD08
ATC
fluticasone; nasal
1.3
15.7
1255
10023
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
33.4
15.7
20
6
J46
ICD-10 Finland
Status asthmaticus
2.5
15.7
124
505
H05.2
ICD-10 Finland
Exophthalmic conditions
8.3
15.7
34
41
A10AA02
ATC
NA
2.5
15.7
124
506
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
15.6
213
1112
E89.31
ICD-10 Finland
Postirradiation hypopituitarism
+∞
15.6
15
*
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
7.5
15.6
36
48
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.4
15.6
135
576
130
Kela drug reimbursment
Malignant tumour
1.8
15.5
268
1518
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
15.5
120
484
N97.8
ICD-10 Finland
Female infertility of other origin
2.8
15.5
101
369
R52.2
ICD-10 Finland
Other chronic pain
2.3
15.5
143
629
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
6.4
15.4
40
63
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.8
15.4
99
356
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.6
15.4
115
453
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
4.6
15.4
53
117
C10AA03
ATC
pravastatin; oral
2.0
15.4
204
1054
J05AB11
ATC
valaciclovir; oral
1.5
15.3
556
3846
R03BA08
ATC
ciclesonide; inhalant
1.7
15.3
347
2138
R03AC12
ATC
salmeterol; inhalant
2.1
15.3
177
865
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.7
15.2
66
180
C03AA03
ATC
hydrochlorothiazide; oral
1.7
15.2
323
1951
C10AC01
ATC
colestyramine; oral
2.5
15.2
115
458
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
15.2
160
750
BBA50
NOMESCO Finland
Total parathyroidectomy
28.7
15.2
20
7
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
6.9
15.1
37
54
R60.0
ICD-10 Finland
Localized oedema
1.6
15.0
392
2508
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.6
15.0
68
193
SPAT1254
SPAT
Administration of medicine
1.5
15.0
515
3519
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.2
15.0
158
742
C02AC05
ATC
moxonidine; oral
2.3
14.9
137
603
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
14.9
369
2328
R4130
NOMESCO Finland
Speech therapy
2.9
14.9
91
317
SPAT1301
SPAT
No procedures
1.3
14.9
1241
9962
R49.01
ICD-10 Finland
Functional dysphonia
2.2
14.9
147
670
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
14.8
1317
10673
XCK00
NOMESCO Finland
Perimetry
1.8
14.8
256
1454
C739
ICD-10 Finland
NA
18.4
14.7
22
12
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.7
14.7
49
105
G44.2
ICD-10 Finland
Tension-type headache
1.5
14.6
581
4097
E29.1
ICD-10 Finland
Testicular hypofunction
5.4
14.6
43
80
WA039
NOMESCO Finland
Radiotherapy with free isotopes
+∞
14.6
14
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.8
14.6
61
162
N06AB10
ATC
escitalopram; oral
1.4
14.5
870
6625
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.1
14.5
158
753
A01AB09
ATC
miconazole; local oral
1.6
14.5
363
2296
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.2
14.5
54
129
TAB00
NOMESCO Finland
Lumbar puncture
2.0
14.5
195
1012
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
14.5
176
879
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
14.5
361
2283
ZX121
NOMESCO Finland
Central venous catheter
7.3
14.4
34
47
WW300
NOMESCO Finland
Transfer of autologic stem cells
7.3
14.4
34
47
N05BA01
ATC
diazepam; systemic, rectal
1.5
14.3
512
3529
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
14.2
215
1164
B01AB04
ATC
dalteparin; parenteral
2.0
14.2
182
928
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
14.1
107
427
I50.0
ICD-10 Finland
Congestive heart failure
2.1
14.1
161
783
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
14.1
566
4002
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
14.0
385
2495
J05AB01
ATC
aciclovir; systemic
1.4
14.0
901
6941
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.2
13.9
135
610
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
6.1
13.9
37
61
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
13.9
671
4917
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.8
13.8
246
1411
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
2.9
13.8
81
278
E24.8
ICD-10 Finland
Other Cushing syndrome
53.5
13.8
16
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
20.1
13.8
20
10
3025
Kela drug reimbursment
Calcium carbonate
20.1
13.8
20
10
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
13.6
184
957
M03BX02
ATC
tizanidine; oral
1.3
13.6
2849
25650
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
13.6
602
4334
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
13.6
447
3024
BCA30
NOMESCO Finland
Unilateral adrenalectomy
12.0
13.6
24
20
IBZ08
NOMESCO Finland
Gender identity assessment
14.7
13.5
22
15
E89
ICD-10 Finland
Postprocedural endocrine and metabolic disorders, not elsewhere classified
+∞
13.5
13
*
E89.8
ICD-10 Finland
Other postprocedural endocrine and metabolic disorders
+∞
13.5
13
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.9
13.5
54
138
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
13.5
318
1981
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
13.5
479
3298
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
13.5
1117
8937
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
6.3
13.5
35
56
SPAT1255
SPAT
Intravenous administration of medicine
1.8
13.5
228
1287
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
13.4
302
1855
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
13.4
344
2191
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
13.4
674
4971
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
13.4
275
1646
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
13.4
156
766
R00.2
ICD-10 Finland
Palpitations
1.7
13.4
298
1826
GB1AA
NOMESCO Finland
Tracheal X-ray examination
18.2
13.3
20
11
C07AA07
ATC
sotalol; systemic
2.3
13.3
118
512
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.5
13.3
103
418
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.8
13.2
86
313
N06AA09
ATC
amitriptyline; systemic
1.6
13.2
397
2631
207
Kela drug reimbursment
Chronic arrhythmias
1.6
13.2
380
2493
CAC44
NOMESCO Finland
Combined decompression of orbit
40.2
13.1
16
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
13.1
796
6069
R03AK08
ATC
formoterol and beclometasone; inhalant
2.0
13.1
158
787
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
13.1
122
544
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
13.0
175
908
A08
ICPC
Swelling
2.1
13.0
151
740
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
13.0
434
2947
E21.2
ICD-10 Finland
Other hyperparathyroidism
6.0
13.0
35
59
E0000UV
ATC
NA
1.3
13.0
1694
14394
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
13.0
197
1072
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
12.9
173
899
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
10.0
12.9
25
25
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
12.9
1674
14206
BAA99
NOMESCO Finland
Other operation on thyroid gland
22.6
12.9
18
8
UJD02
NOMESCO Finland
Gastroscopy
1.9
12.9
176
921
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
12.9
260
1552
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
12.8
171
887
R03AC03
ATC
terbutaline; inhalant
1.4
12.7
591
4294
6171A
ICD-9 Finland
Endometriosis of ovary
2.9
12.7
76
265
B81
ICPC
Anaemia vit B12/folate deficiency
2.2
12.7
130
605
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
12.7
518
3670
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.8
12.7
219
1245
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
12.6
114
501
L02AE03
ATC
goserelin; implant
3.2
12.6
64
200
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
32.1
12.6
16
5
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
12.5
463
3211
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
12.5
275
1682
107
Kela drug reimbursment
Pernicious anaemia
2.8
12.5
79
286
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.2
12.5
46
110
2AX04
NOMESCO Finland
NA
24.3
12.4
17
7
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
24.3
12.4
17
7
GDG10
NOMESCO Finland
Bilateral transplantation of lung
20.1
12.4
18
9
R2110
NOMESCO Finland
Giving the first information
1.6
12.4
308
1947
UDC00
NOMESCO Finland
Ear microscopy
1.7
12.3
270
1646
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
12.3
1206
9862
A10AA01
ATC
NA
2.4
12.3
100
417
M54.5
ICD-10 Finland
Low back pain
1.3
12.3
1360
11298
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
12.3
367
2430
B01AF02
ATC
apixaban; oral
1.7
12.3
266
1620
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.0
12.3
165
859
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
14.3
12.2
20
14
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
14.3
12.2
20
14
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
14.3
12.2
20
14
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.3
12.2
106
457
SPAT1325
SPAT
Vaccination
1.3
12.2
1310
10834
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
12.2
408
2770
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.5
12.2
56
162
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
12.2
491
3470
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
12.1
75
265
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
12.1
1950
16938
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
12.1
329
2126
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.4
12.1
43
99
T99
ICPC
Endocr/metab/nutrit disease other
3.0
12.1
70
238
R07.3
ICD-10 Finland
Other chest pain
1.6
12.1
319
2046
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
6.9
12.1
29
42
H50.6
ICD-10 Finland
Mechanical strabismus
26.7
12.0
16
6
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
12.0
312
1994
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
12.0
876
6866
A10BH01
ATC
sitagliptin; oral
1.7
12.0
258
1566
A10BH05
ATC
linagliptin; oral
2.2
12.0
120
554
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
12.0
1145
9327
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
13.4
11.9
20
15
N80.0
ICD-10 Finland
Endometriosis of uterus
2.2
11.9
122
569
C10AA04
ATC
fluvastatin; oral
1.7
11.9
223
1303
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
11.8
365
2434
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.9
11.8
166
880
Y28
ICPC
Limited function/disability (Y)
11.7
11.8
21
18
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.7
11.8
80
303
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
6.1
11.8
31
51
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
11.8
993
7949
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
14.7
11.8
19
13
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
11.8
191
1065
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
11.7
264
1623
J02AC03
ATC
voriconazole; systemic
9.6
11.7
23
24
8442/1-C56.9
ICD-O-3
Serous borderline tumor, NOS, of ovary
6.6
11.7
29
44
R03DA04
ATC
theophylline; systemic, rectal
1.9
11.6
166
882
J01EA01
ATC
trimethoprim; systemic
1.3
11.6
1100
8945
E06.9
ICD-10 Finland
Thyroiditis, unspecified
6.0
11.6
31
52
8345/3-C73.9
ICD-O-3
Medullary thyroid carcinoma of thyroid gland
65.1
11.6
13
*
E20
ICD-10 Finland
Hypoparathyroidism
65.1
11.6
13
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
18.9
11.6
17
9
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.2
11.6
117
543
WW409
NOMESCO Finland
Other aferesis
8.1
11.5
25
31
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
11.5
1674
14350
KBV10
NOMESCO Finland
Removal of stent from ureter
4.6
11.5
39
86
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.6
11.5
283
1783
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
11.5
84
330
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.6
11.5
81
313
A01
ICPC
Pain general/multiple sites
1.6
11.5
286
1810
R21
ICPC
Throat symptom/complaint
1.3
11.5
837
6555
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
11.5
163
867
2513A
ICD-9 Finland
Other disorders of pancreatic internal secretion, Postsurgical hypoinsulinaemia
+∞
11.5
11
*
HA1AA
NOMESCO Finland
X-ray mammography
1.5
11.4
344
2279
JEA00
NOMESCO Finland
Appendectomy
1.7
11.4
246
1493
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.3
11.4
105
465
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
11.4
456
3215
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.1
11.4
121
574
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.9
11.4
69
244
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
11.4
967
7742
SPAT1097
SPAT
Recording of ECG
1.4
11.4
501
3602
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
2.7
11.3
75
278
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.9
11.3
174
953
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
4.0
11.3
44
111
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
7.8
11.3
25
32
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
11.8
11.3
20
17
LAE10
NOMESCO Finland
Unilateral oophorectomy
5.5
11.3
32
58
N05AH04
ATC
quetiapine; oral
1.4
11.3
611
4558
LAD00
NOMESCO Finland
Partial excision of ovary
8.3
11.3
24
29
J45
ICD-10 Finland
Asthma
1.5
11.3
389
2660
E27.2
ICD-10 Finland
Addisonian crisis
35.1
11.3
14
*
M05BA04
ATC
alendronic acid; oral
1.6
11.2
302
1950
SPAT1260
SPAT
Consultation of another employee
1.4
11.2
657
4973
XG466
NOMESCO Finland
Sleep oxymetry
2.2
11.2
109
498
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
5.3
11.1
33
63
D07AA02
ATC
hydrocortisone; topical
1.4
11.1
542
3969
H50.8
ICD-10 Finland
Other specified strabismus
12.7
11.1
19
15
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
11.1
226
1355
L02AE02
ATC
leuprorelin; implant, parenteral
2.1
11.1
125
607
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
6.4
11.0
28
44
F29
ICPC
Eye symptom/complaint other
1.6
11.0
317
2080
M01AX17
ATC
nimesulide; oral
1.3
11.0
944
7562
WW402
NOMESCO Finland
Leucoferesis
11.1
11.0
20
18
UDQ02
NOMESCO Finland
Direct laryngoscopy
3.7
11.0
46
124
GD6AD
NOMESCO Finland
CT of chest and neck
8.5
11.0
23
27
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
10.0
11.0
21
21
R55
ICD-10 Finland
Syncope and collapse
1.5
10.9
322
2126
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
43.4
10.9
13
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
10.8
1054
8592
PJD99
NOMESCO Finland
Excision of other lymph nodes
11.9
10.8
19
16
N19
ICD-10 Finland
Unspecified kidney failure
2.5
10.8
80
318
WX882
NOMESCO Finland
High dependency care
2.3
10.8
95
412
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
10.8
478
3440
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
10.8
486
3508
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
10.8
357
2422
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
8.8
10.7
22
25
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.9
10.7
147
773
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
10.7
568
4223
24110
ICD-8 Finland
Non-toxic nodular goitre, Sporadic
9.6
10.7
21
22
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.1
10.7
58
191
24400
ICD-8 Finland
Myxoedema, (hypothyreosis) post therapiam
17.8
10.7
16
9
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.0
10.7
140
722
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.2
10.7
105
480
Z94.0
ICD-10 Finland
Kidney transplant status
4.0
10.6
41
103
L60.0
ICD-10 Finland
Ingrowing nail
1.9
10.6
154
827
R52.9
ICD-10 Finland
Pain, unspecified
1.5
10.6
315
2082
R03BA05
ATC
fluticasone; inhalant
1.3
10.6
742
5771
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.1
10.6
110
518
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
10.6
156
844
JAL31
NOMESCO Finland
Laparoscopic omentectomy
6.0
10.5
28
47
C09CA06
ATC
candesartan; oral
1.3
10.5
797
6268
KFC00
NOMESCO Finland
Unilateral orchiectomy
5.7
10.5
29
51
J01DA06
ATC
[U] cefuroxime; systemic
1.4
10.5
583
4368
M05BX04
ATC
denosumab; parenteral
1.8
10.5
180
1023
B02.9
ICD-10 Finland
Zoster without complication
1.7
10.5
196
1144
E06.0
ICD-10 Finland
Acute thyroiditis
9.2
10.5
21
23
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
10.5
222
1346
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
6.5
10.5
26
40
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
6.5
10.5
26
40
RS221
NOMESCO Finland
NA
2.8
10.4
65
232
K30
ICD-10 Finland
Functional dyspepsia
1.5
10.4
410
2880
E90
ICD-10 Finland
Nutritional and metabolic disorders in diseases classified elsewhere
110.2
10.4
11
*
E89.3
ICD-10 Finland
Postprocedural hypopituitarism
+∞
10.4
10
*
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
10.4
716
5553
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
10.4
127
637
C09AA02
ATC
enalapril; systemic
1.4
10.4
581
4356
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
5.4
10.4
30
56
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.8
10.4
723
9063
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.3
10.3
50
152
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
10.3
1646
14216
T81
ICPC
Goitre
5.1
10.3
31
61
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
10.3
183
1052
E23.03
ICD-10 Finland
Lack of ACTH
10.6
10.3
19
18
R10.0
ICD-10 Finland
Acute abdomen
2.1
10.3
119
585
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
10.2
634
4836
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.8
10.2
42
112
D35.30
ICD-10 Finland
Craniopharyngoma
23.4
10.2
14
6
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
13.1
10.1
17
13
N05CD07
ATC
temazepam; oral
1.5
10.1
402
2830
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
10.1
144
768
C01DA14
ATC
isosorbide mononitrate; oral
1.5
10.1
296
1952
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
10.1
333
2257
WX872
NOMESCO Finland
Intensive care
2.0
10.1
123
621
-50
ICPC
Medication/prescr/renewal
1.9
10.0
151
821
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
4.5
10.0
34
76
H3600, E103
ICD-10 Finland
NA
3.4
10.0
46
135
LAC00
NOMESCO Finland
Excision of ovarian cyst
6.4
10.0
25
39
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
10.0
1351
11446
C01BD01
ATC
amiodarone; systemic
2.5
10.0
75
302
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.1
9.9
110
532
D01
ICPC
Abdominal pain/cramps general
1.4
9.9
409
2903
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
4.4
9.9
34
77
5AB14
NOMESCO Finland
NA
16.7
9.9
15
9
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.9
9.9
142
762
WX723
NOMESCO Finland
CPAP therapy
2.0
9.8
119
599
J02AC04
ATC
posaconazole; systemic
26.0
9.8
13
5
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
26.0
9.8
13
5
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
9.8
402
2852
J43.1
ICD-10 Finland
Panlobular emphysema
20.0
9.8
14
7
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
20.0
9.8
14
7
J01CA08
ATC
pivmecillinam; oral
1.2
9.8
1954
17254
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.6
9.7
70
275
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
9.5
9.7
19
20
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
9.7
363
2523
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.3
9.7
88
388
A46
ICD-10 Finland
Erysipelas
1.4
9.7
412
2941
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
9.7
470
3439
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
7.4
9.7
22
30
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
7.4
9.7
22
30
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
2.0
9.7
126
652
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
4.6
9.7
32
70
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.8
9.7
39
103
J96.1
ICD-10 Finland
Chronic respiratory failure
2.8
9.6
59
212
TPH00
NOMESCO Finland
Phlebotomy
5.8
9.6
26
45
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
5.8
9.6
26
45
R09
ICPC
Sinus symptom/complaint
1.5
9.6
326
2223
A29
ICPC
General symptom/complaint other
1.5
9.6
383
2701
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.4
9.6
77
322
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
9.6
353
2445
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
9.6
188
1115
A03DA02
ATC
pitofenone and analgesics; systemic
2.4
9.6
79
334
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
9.6
261
1693
C08DB01
ATC
diltiazem; oral
1.9
9.5
137
733
B82
ICPC
Anaemia other/unspecified
2.4
9.5
78
328
K02.1
ICD-10 Finland
Caries of dentine
1.2
9.5
2467
22327
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
9.5
145
795
H26.4
ICD-10 Finland
After-cataract
1.6
9.5
263
1710
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.0
9.5
118
599
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
5.7
9.5
26
46
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
3.8
9.5
38
100
UJK02
NOMESCO Finland
ERCP
2.3
9.5
82
357
XA800
NOMESCO Finland
Neuropsychological investigation
1.9
9.4
135
724
A10AE06
ATC
insulin degludec; parenteral
2.1
9.4
97
456
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
100.2
9.4
10
*
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
100.2
9.4
10
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.9
9.4
134
716
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
9.4
229
1444
2521A
ICD-9 Finland
Disorders of parathyroid gland, Hypoparathyroidism
+∞
9.4
9
*
2572A
ICD-9 Finland
Testicular dysfunction, Other testicular hypofunction
+∞
9.4
9
*
N05CF02
ATC
zolpidem; oral
1.3
9.4
722
5688
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.5
9.3
308
2086
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
9.3
411
2952
A01AB04
ATC
amphotericin B; local oral
1.7
9.3
176
1031
6BA02
NOMESCO Finland
NA
6.9
9.3
22
32
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.4
9.3
77
327
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
9.3
276
1826
P06
ICPC
Sleep disturbance
1.5
9.3
359
2518
QDJ00
NOMESCO Finland
Liposuction in lower extremity
10.7
9.3
17
16
R96
ICPC
Asthma
1.5
9.3
330
2272
WX610
NOMESCO Finland
Patient controlled analgesia
4.3
9.3
33
78
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
9.2
525
3948
5BA08
NOMESCO Finland
NA
4.5
9.2
31
69
M01AH02
ATC
rofecoxib; oral
1.4
9.2
487
3615
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
9.2
581
4441
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.8
9.2
146
810
FM2CE
NOMESCO Finland
NA
7.3
9.2
21
29
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
7.3
9.2
21
29
K90.0
ICD-10 Finland
Coeliac disease
1.9
9.1
120
624
N06AB03
ATC
fluoxetine; oral
1.4
9.1
492
3666
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.8
9.1
153
867
J45.8
ICD-10 Finland
Mixed asthma
2.0
9.1
109
548
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
9.1
237
1521
24220
ICD-8 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre
11.5
9.0
16
14
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
8.3
9.0
19
23
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
9.0
431
3143
H57.1
ICD-10 Finland
Ocular pain
1.9
9.0
119
620
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
9.0
209
1300
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.7
9.0
61
231
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
9.0
73
308
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.5
9.0
298
2021
R4120
NOMESCO Finland
Occupational therapy
1.6
9.0
220
1386
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
9.0
239
1538
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
9.0
81
359
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.9
9.0
35
90
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.5
9.0
68
275
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
8.9
266
1762
D07AC01
ATC
betamethasone; topical
1.2
8.9
1333
11394
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
18.6
8.9
13
7
B03XA02
ATC
darbepoetin alfa; parenteral
3.0
8.9
49
165
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.1
8.9
96
462
H03BB02
ATC
thiamazole; oral
24.0
8.9
12
5
UJC01
NOMESCO Finland
Scopy of lower throat
3.5
8.9
39
111
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
8.9
128
688
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
8.9
93
441
K92.1
ICD-10 Finland
Melaena
1.9
8.9
128
689
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
8.8
194
1188
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
7.9
8.8
19
24
C09DA01
ATC
losartan and diuretics; oral
1.5
8.8
325
2257
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.5
8.8
65
261
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.5
8.8
67
272
E28.3
ICD-10 Finland
Primary ovarian failure
4.9
8.8
27
55
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
8.8
885
7226
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.2
8.7
87
404
K80
ICPC
Cardiac arrhythmia NOS
1.5
8.7
253
1663
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
8.7
283
1910
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
5.9
8.7
23
39
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
8.7
647
5070
Z00.8
ICD-10 Finland
Other general examinations
1.6
8.7
241
1570
L95
ICPC
Osteoporosis
1.9
8.7
116
606
E85.9
ICD-10 Finland
Amyloidosis, unspecified
50.1
8.7
10
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
8.7
103
515
L12
ICPC
Hand/finger symptom/complaint
1.4
8.7
529
4023
J43.9
ICD-10 Finland
Emphysema, unspecified
3.1
8.7
45
146
8204
FHL
Salpingo-oophorectomy
2.7
8.6
56
209
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.6
8.6
229
1476
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
8.6
182
1104
M25.5
ICD-10 Finland
Pain in joint
1.2
8.6
1171
9901
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
8.6
205
1284
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.0
8.6
46
152
L91.0
ICD-10 Finland
Hypertrophic scar
2.6
8.6
61
240
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.5
8.6
38
109
R31
ICD-10 Finland
Unspecified haematuria
1.6
8.6
241
1572
M48.0
ICD-10 Finland
Spinal stenosis
1.4
8.6
364
2600
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.6
8.6
59
227
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.3
8.6
30
70
N06AB04
ATC
citalopram; systemic
1.3
8.6
847
6895
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
16.3
8.5
13
8
LCD30
NOMESCO Finland
Radical hysterectomy
6.9
8.5
20
29
E23.2
ICD-10 Finland
Diabetes insipidus
6.9
8.5
20
29
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
8.5
542
4147
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
8.5
140
786
B02AA02
ATC
tranexamic acid; systemic
1.3
8.5
680
5380
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
8.5
434
3208
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
20.0
8.5
12
6
CAC20
NOMESCO Finland
Lateral decompression of orbit
20.0
8.5
12
6
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.2
8.4
82
375
G03HA01
ATC
cyproterone; systemic
4.5
8.4
28
62
WX780
NOMESCO Finland
Remote monitoring CPAP
1.9
8.4
126
685
M01AG01
ATC
mefenamic acid; oral
1.9
8.4
116
613
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.0
8.4
22
37
I50.1
ICD-10 Finland
Left ventricular failure
2.0
8.4
101
507
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
90.2
8.4
9
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.6
8.4
203
1279
D11
ICPC
Diarrhoea
1.4
8.4
417
3065
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.7
8.4
35
96
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.4
8.3
65
269
E83.59
ICD-10 Finland
Other disorders of calcium metabolism
+∞
8.3
8
*
2726A
ICD-9 Finland
Disorders of lipoid metabolism, Lipodystrophy
+∞
8.3
8
*
5AD01
NOMESCO Finland
NA
+∞
8.3
8
*
E85.0
ICD-10 Finland
Non-neuropathic heredofamilial amyloidosis
+∞
8.3
8
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
8.3
244
1609
WX722
NOMESCO Finland
PEEP
1.8
8.3
131
726
A12BA01
ATC
potassium chloride; oral
1.9
8.3
117
622
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.3
8.3
73
318
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.0
8.3
100
502
L03
ICPC
Low back symptom/complaint
1.3
8.3
936
7742
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.4
8.3
65
271
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
8.3
129
716
C01AA05
ATC
digoxin; systemic
1.7
8.2
175
1065
R25.1
ICD-10 Finland
Tremor, unspecified
2.1
8.2
89
430
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
8.2
81
375
N01
ICPC
Headache
1.4
8.2
382
2776
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
8.2
349
2491
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.2
47
161
J31.0
ICD-10 Finland
Chronic rhinitis
1.5
8.2
291
2005
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.6
8.2
205
1302
E83.1
ICD-10 Finland
Disorders of iron metabolism
7.5
8.1
18
24
H01CB02
ATC
octreotide; parenteral
6.0
8.1
21
35
A10BK03
ATC
empagliflozin; oral
1.6
8.1
190
1186
Z50.5
ICD-10 Finland
Speech therapy
2.6
8.1
57
224
TPX15
NOMESCO Finland
Removal of vascular injection port
4.3
8.1
28
65
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
8.1
297
2060
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.7
8.1
146
849
L02
ICPC
Back symptom/complaint
1.4
8.1
342
2442
TGC00
NOMESCO Finland
Bronchial lavation
2.2
8.1
80
372
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
33.4
8.1
10
*
E05.3
ICD-10 Finland
Thyrotoxicosis from ectopic thyroid tissue
33.4
8.1
10
*
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
33.4
8.1
10
*
R05
ICD-10 Finland
Cough
1.3
8.1
717
5755
C07AG02
ATC
carvedilol; oral
1.7
8.1
151
887
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
17.2
8.1
12
7
N17
ICPC
Vertigo/dizziness
1.4
8.0
366
2646
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
6.8
8.0
19
28
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.4
8.0
347
2487
KAC10
NOMESCO Finland
Total nephrectomy with capsule
4.0
8.0
30
75
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.7
8.0
52
195
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.4
8.0
449
3372
M01AE02
ATC
naproxen; oral, rectal
1.2
8.0
2489
22762
A60
ICPC
General and Unspecified, Result test/procedure
1.7
8.0
153
903
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
7.2
7.9
18
25
RS222
NOMESCO Finland
NA
2.9
7.9
46
160
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
7.9
142
821
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.7
7.9
52
197
JFB46
NOMESCO Finland
Resection of sigmoid colon
3.0
7.9
43
145
JLC10
NOMESCO Finland
Distal pancreatectomy
7.7
7.9
17
22
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
7.9
222
1455
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
7.8
906
7514
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.7
7.8
140
812
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.8
7.8
127
714
A27
ICPC
Fear of other disease NOS
1.7
7.8
152
902
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.9
7.8
30
77
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
7.8
111
596
LEB00
NOMESCO Finland
Biopsy of vagina
2.1
7.8
81
386
A03FA02
ATC
cisapride; oral, rectal
1.5
7.8
263
1795
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.1
7.8
83
400
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
6.9
7.8
18
26
R01AD12
ATC
fluticasone furoate; nasal
1.2
7.8
1283
11055
E000001
ATC
NA
1.3
7.8
818
6710
G04CA02
ATC
tamsulosin; oral
1.4
7.7
378
2771
E000003
ATC
NA
1.6
7.7
170
1046
EB1WA
NOMESCO Finland
NA
3.7
7.7
32
88
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.2
7.7
70
314
ZX197
NOMESCO Finland
NA
15.0
7.7
12
8
LAC01
NOMESCO Finland
Laparoscopic excision of ovarian cyst
2.2
7.7
75
347
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
7.7
429
3217
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.9
7.7
114
622
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
4.1
7.6
28
69
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
7.6
162
984
I95.1
ICD-10 Finland
Orthostatic hypotension
2.1
7.6
80
383
S01
ICPC
Pain/tenderness of skin
1.8
7.6
136
786
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
7.6
118
654
XX9XW
NOMESCO Finland
NA
3.6
7.6
32
89
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.2
7.6
72
329
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
7.6
755
6142
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.7
7.6
24
51
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
18.4
7.6
11
6
R04.0
ICD-10 Finland
Epistaxis
1.6
7.6
188
1195
A98
ICPC
Health maint/preventive medicine
1.4
7.6
4740
46310
N17.8
ICD-10 Finland
Other acute renal failure
4.2
7.6
27
65
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
25.0
7.6
10
*
C01CA24
ATC
epinephrine; parenteral
1.5
7.6
250
1696
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.9
7.6
44
154
C10AB05
ATC
fenofibrate; oral
2.7
7.5
49
184
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
8.8
7.5
15
17
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
7.5
122
683
T28
ICPC
Limited function/disability (T)
3.1
7.5
38
122
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
7.5
696
5612
R06AX26
ATC
fexofenadine; oral
1.5
7.5
267
1841
CA1BD
NOMESCO Finland
Extensive orbita CT
10.0
7.5
14
14
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.7
7.5
48
177
H04AA01
ATC
glucagon; nasal, parenteral
2.1
7.5
78
370
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
7.5
94
482
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.5
647
5175
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
7.5
477
3654
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
7.5
90
456
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.5
7.5
33
96
N03AF01
ATC
carbamazepine; oral, rectal
1.6
7.4
167
1033
I50
ICD-10 Finland
Heart failure
2.3
7.4
65
286
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
7.4
180
1137
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.8
7.4
114
630
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
4.4
7.4
25
57
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
7.4
108
586
XF602
NOMESCO Finland
Bloodpressure monitoring
3.2
7.4
37
118
321
Kela drug reimbursment
Paricalcitol and cinacalcet
5.0
7.4
22
44
R05FB02
ATC
cough suppressants and expectorants
1.2
7.4
1508
13253
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
4.2
7.4
26
62
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.2
7.4
72
332
A03
ICPC
Fever
1.3
7.4
600
4761
Z93.2
ICD-10 Finland
Ileostomy status
6.0
7.4
19
32
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
7.4
137
803
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
5.6
7.4
20
36
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.9
7.3
99
521
R35
ICD-10 Finland
Polyuria
1.6
7.3
171
1070
D06
ICPC
Abdominal pain localized other
1.4
7.3
300
2126
R03AC13
ATC
formoterol; inhalant
1.6
7.3
172
1076
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.8
7.3
109
596
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
7.3
402
3009
2754A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]
+∞
7.3
7
*
E87.2
ICD-10 Finland
Acidosis
+∞
7.3
7
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
+∞
7.3
7
*
E27.0
ICD-10 Finland
Other adrenocortical overactivity
10.9
7.3
13
12
YNB10
NOMESCO Finland
Collection of stem cells for transplant
6.8
7.3
17
25
C90.0
ICD-10 Finland
Multiple myeloma
3.2
7.3
35
109
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
7.2
299
2126
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
15.7
7.2
11
7
24100
ICD-8 Finland
Non-toxic nodular goitre, Endemic
15.7
7.2
11
7
2429X
ICD-9 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause
15.7
7.2
11
7
S97
ICPC
Chronic ulcer skin
1.7
7.2
141
840
ZX112
NOMESCO Finland
Subcutaneous
2.1
7.2
76
364
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.0
7.2
85
425
6173A
ICD-9 Finland
Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]
2.9
7.2
42
148
N97.1
ICD-10 Finland
Female infertility of tubal origin
2.6
7.2
48
185
KBV00
NOMESCO Finland
Insertion of stent into ureter
4.1
7.2
26
64
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
7.2
51
203
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
7.1
1662
14768
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
3.3
7.1
34
105
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.1
1017
8622
ED1AA
NOMESCO Finland
Mandipular X-ray examination
3.8
7.1
28
74
I20.09
ICD-10 Finland
Unstable angina
1.8
7.1
111
614
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
20.0
7.1
10
5
E000006
ATC
NA
1.5
7.1
269
1880
J37.0
ICD-10 Finland
Chronic laryngitis
1.8
7.1
111
617
WX290
NOMESCO Finland
Other blockade of nerve
1.2
7.1
1849
16586
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.4
7.1
54
223
L20
ICPC
Joint symptom/complaint NOS
1.7
7.1
129
751
J01DC02
ATC
cefuroxime; systemic
1.5
7.1
222
1491
M13.9
ICD-10 Finland
Arthritis, unspecified
1.5
7.1
241
1650
H01CB03
ATC
lanreotide; parenteral
5.6
7.0
19
34
M02AA07
ATC
piroxicam; topical
1.2
7.0
1431
12558
8201
FHL
Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis
2.2
7.0
68
315
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
7.0
689
5595
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
7.0
2365
21665
N80
ICD-10 Finland
Endometriosis
3.1
7.0
35
112
A02BX02
ATC
sucralfate; oral
1.7
7.0
136
810
R05
ICPC
Cough
1.2
7.0
861
7181
C08DA01
ATC
verapamil; systemic
1.7
7.0
129
757
CEC00
NOMESCO Finland
Recession of extraocular muscle
4.3
7.0
24
56
R03BC03
ATC
nedocromil; inhalant
1.4
7.0
276
1943
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
7.0
7.0
16
23
602
Kela drug reimbursment
Children's severe malnutrition
7.0
7.0
16
23
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.3
7.0
60
264
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
7.0
316
2288
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.1
7.0
25
61
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
7.0
132
781
A97
ICPC
No disease
1.3
6.9
521
4086
ZXB10
NOMESCO Finland
Medial
3.8
6.9
27
71
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
6.9
181
1166
N04BC06
ATC
cabergoline; oral (dopamine agonists)
3.7
6.9
28
76
SPAT1336
SPAT
Request for examination
1.7
6.9
130
767
LAD01
NOMESCO Finland
Laparoscopic partial excision of ovary
4.4
6.9
23
52
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
1.9
6.9
88
456
8472/1-C56.9
ICD-O-3
Mucinous cystic tumor of borderline malignancy of ovary
6.3
6.9
17
27
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.1
6.9
74
357
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.5
6.9
229
1556
R06.2
ICD-10 Finland
Wheezing
1.7
6.9
145
882
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.0
6.9
77
380
H02AB02
ATC
dexamethasone; systemic
1.4
6.9
375
2801
LAE11
NOMESCO Finland
Unilateral laparoscopic oophorectomy
3.2
6.9
34
108
A10BB12
ATC
glimepiride; oral
1.6
6.9
150
923
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.9
320
2325
1CX01
NOMESCO Finland
NA
7.5
6.9
15
20
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.0
6.9
78
384
S22
ICPC
Nail symptom/complaint
1.6
6.9
188
1226
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
6.8
81
409
N83.1
ICD-10 Finland
Corpus luteum cyst
2.3
6.8
61
272
RL210
NOMESCO Finland
NA
3.8
6.8
27
72
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
8.3
6.8
14
17
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
6.8
293
2103
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.7
6.8
42
155
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
6.8
339
2498
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
6.8
167
1062
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
10.9
6.8
12
11
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.8
2267
20736
N02AC04
ATC
dextropropoxyphene; oral
1.8
6.8
110
619
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
6.8
239
1649
R06.5
ICD-10 Finland
Mouth breathing
1.4
6.8
273
1934
JMA10
NOMESCO Finland
Transabdominal total splenectomy
4.0
6.8
25
63
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
6.1
6.8
17
28
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.8
6.8
110
621
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.6
6.7
28
78
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.7
6.7
119
688
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
6.7
1170
10110
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
6.7
4262
41140
3AC01
NOMESCO Finland
NA
2.9
6.7
39
137
M01AE51
ATC
ibuprofen, combinations; systemic
2.2
6.7
60
269
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
22.5
6.7
9
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
3.1
6.7
34
111
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
6.7
178
1153
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.5
6.7
48
193
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.2
6.6
65
303
J01FA15
ATC
telithromycin; oral
1.3
6.6
392
2969
N30.0
ICD-10 Finland
Acute cystitis
1.3
6.6
510
4016
SPAT1251
SPAT
Organisation of medication
1.8
6.6
109
620
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
6.6
290
2087
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.0
6.6
34
112
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.0
6.6
34
112
D02AE01
ATC
carbamide; topical
1.5
6.6
241
1676
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.7
6.6
43
163
K05.1
ICD-10 Finland
Chronic gingivitis
1.4
6.6
272
1938
E06.5
ICD-10 Finland
Other chronic thyroiditis
12.2
6.6
11
9
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
3.9
6.5
25
65
J01MA06
ATC
norfloxacin; oral
1.3
6.5
536
4252
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.2
6.5
62
286
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
10.0
6.5
12
12
S10
ICPC
Boil/carbuncle
1.6
6.5
170
1094
2AB04
NOMESCO Finland
NA
4.3
6.5
22
51
E73.9
ICD-10 Finland
Lactose intolerance, unspecified
6.8
6.5
15
22
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
6.5
702
5768
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.3
6.5
56
247
H53.4
ICD-10 Finland
Visual field defects
2.2
6.5
61
279
K86.1
ICD-10 Finland
Other chronic pancreatitis
3.5
6.5
28
81
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
5.0
6.5
19
38
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.8
6.5
109
621
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
6.5
194
1293
H65.0
ICD-10 Finland
Acute serous otitis media
2.2
6.5
59
268
137
Kela drug reimbursment
Uraemia requiring dialysis
3.7
6.4
26
71
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.7
6.4
118
690
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
2.2
6.4
58
260
SPAT1281
SPAT
Other administrative function
1.4
6.4
270
1929
2AX05
NOMESCO Finland
NA
69.9
6.4
7
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
69.9
6.4
7
*
1DB06
NOMESCO Finland
NA
69.9
6.4
7
*
JAL30
NOMESCO Finland
Omentectomy
2.4
6.4
49
202
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
2.2
6.4
59
269
N06AA12
ATC
doxepin; systemic
1.6
6.4
172
1116
P01BA02
ATC
hydroxychloroquine; oral
1.4
6.4
320
2359
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.5
6.4
240
1677
R28
ICPC
Limited function/disability (R)
2.6
6.4
42
160
212
Kela drug reimbursment
Gout
2.6
6.4
42
160
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
3.2
6.4
31
98
1410
FHL
Laparoscopy
1.7
6.4
121
715
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
14.3
6.4
10
7
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
4.7
6.4
20
43
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.9
6.4
37
130
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
2.6
6.4
45
177
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.6
6.4
45
177
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
6.4
193
1291
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
3.1
6.4
32
104
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.5
6.3
45
178
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
6.5
6.3
15
23
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
6.3
126
759
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.2
6.3
62
289
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
5.9
6.3
16
27
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
5.9
6.3
16
27
G03CA04
ATC
estriol; systemic, vaginal
1.4
6.3
243
1710
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
6.3
1070
9224
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.0
6.3
72
360
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.1
6.3
32
105
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
6.3
129
784
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
4.6
6.3
20
44
B03XA01
ATC
erythropoietin; parenteral
3.6
6.3
26
73
XX1MN
NOMESCO Finland
Isotope examination with measurement
18.0
6.3
9
5
CD2S4
NOMESCO Finland
Photography of eye
3.8
6.3
24
63
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
3.8
6.3
24
63
WF099
NOMESCO Finland
Other radiotherapy
3.7
6.3
25
68
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
6.2
6
*
2776A
ICD-9 Finland
Other and unspecified disorders of metabolism, Other deficiencies of circulating enzymes[DEFECTUS ALFA1-ANTITRYPSINI]
+∞
6.2
6
*
E8901, E050
ICD-10 Finland
NA
+∞
6.2
6
*
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
+∞
6.2
6
*
E83.58
ICD-10 Finland
Idiopathic hypercalciuria
+∞
6.2
6
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
6.2
444
3458
WX702
NOMESCO Finland
Supraglottic ventilation device
1.5
6.2
193
1295
2422A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic multinodular goitre
26.7
6.2
8
*
LCF00
NOMESCO Finland
Excision of lesion of parametrium
26.7
6.2
8
*
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
26.7
6.2
8
*
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
26.7
6.2
8
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
26.7
6.2
8
*
E06.1
ICD-10 Finland
Subacute thyroiditis
2.7
6.2
38
140
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.8
6.2
92
504
R07.0
ICD-10 Finland
Pain in throat
1.5
6.2
222
1539
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.9
6.2
86
461
QBJ00
NOMESCO Finland
Liposuction in trunk
3.2
6.2
30
95
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
6.2
343
2574
6170A
ICD-9 Finland
Endometriosis of uterus
2.5
6.2
45
183
N06AA10
ATC
nortriptyline; systemic
1.9
6.2
86
463
TK810
NOMESCO Finland
Hemofiltration
5.0
6.2
18
36
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
6.2
265
1903
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
3.8
6.2
24
64
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
5.3
6.1
17
32
A10AB06
ATC
insulin glulisine; parenteral
3.0
6.1
32
107
M50.3
ICD-10 Finland
Other cervical disc degeneration
1.9
6.1
83
440
CEW99
NOMESCO Finland
Other operation on extraocular muscle
7.7
6.1
13
17
M01AB55
ATC
diclofenac, combinations; oral
1.5
6.1
225
1568
A99
ICPC
Disease/condition unspecnature/site
1.4
6.1
256
1831
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
6.1
132
812
X57
ICD-10 Finland
Unspecified privation
2.0
6.1
73
372
R04.2
ICD-10 Finland
Haemoptysis
1.9
6.1
83
442
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.6
6.1
132
814
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
12.5
6.1
10
8
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
12.5
6.1
10
8
XLA10
NOMESCO Finland
NA
1.5
6.1
223
1554
E13
ICD-10 Finland
Other specified diabetes mellitus
8.6
6.0
12
14
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.9
6.0
81
431
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
6.0
259
1860
R06.1
ICD-10 Finland
Stridor
4.4
6.0
20
46
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
2.5
6.0
43
171
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
10.0
6.0
11
11
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
10.0
6.0
11
11
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
10.0
6.0
11
11
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
10.0
6.0
11
11
M01AH05
ATC
etoricoxib; oral
1.2
6.0
2544
23608
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1297
2795
5.71
307.65
4.4
3.1
ng/l
56.5
79.3
19.21
1143
2402
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3554
18878
3.34
307.65
10.8
4.8
mmol/l
1.2
1.2
53.03
3365
17002
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
840
410
23.85
307.65
7.3
3.8
u/ml
48.6
110.0
1.33
308
106
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2142
3048
10.65
307.65
6.6
3.1
pmol/l
4.5
4.5
0.48
2001
2724
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
797
218
42.33
307.65
7.4
5.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1046
1189
10.55
307.65
3.0
1.8
iu/l
11.5
4.1
0.80
613
427
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1337
4418
3.65
307.65
7.8
4.6
mmol/l
1.1
1.0
9.06
1246
4084
(3018418) pH of Serum or Plasma
2807
12257
3.54
307.65
8.3
3.3
ph
7.4
7.4
0.00
581
2366
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3899
20964
3.71
307.65
12.4
5.3
mmol/l
1.2
1.2
51.78
3323
17603
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5191
38273
4.94
303.43
11.5
4.0
pmol/l
16.2
14.6
295.63
4999
35158
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1554
5998
3.19
298.93
5.8
3.1
mmol/l
0.8
0.8
15.79
1463
5582
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3262
19724
2.53
249.28
3.2
2.2
nmol/l
76.7
77.9
1.71
3062
17914
(3015377) Calcium [Moles/volume] in Serum or Plasma
2616
15027
2.37
213.56
4.2
3.2
mmol/l
2.3
2.4
42.09
2391
13187
(3024561) Albumin [Mass/volume] in Serum or Plasma
2936
18061
2.29
199.77
6.6
4.2
g/l
36.0
36.1
0.48
2756
16729
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4590
35085
2.57
175.33
10.9
6.8
u/l
77.1
76.2
0.83
4438
32940
(3036481) Cortisol [Moles/volume] in Serum or Plasma
985
3912
2.83
170.81
2.8
2.1
nmol/l
365.3
370.8
0.21
925
3607
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5320
44488
3.89
161.50
13.1
4.7
mu/l
2.0
2.0
0.00
5115
41157
(3013650) Neutrophils [#/volume] in Blood by Automated count
3718
26535
2.15
158.36
12.5
8.8
e9/l
3.9
3.9
0.15
3323
23224
(3013826) Glucose [Moles/volume] in Serum or Plasma
3526
24840
2.10
152.99
6.9
3.8
mmol/l
6.6
6.5
1.55
3350
22903
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
436
1177
3.93
141.01
1.4
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
340
763
4.68
140.27
2.9
2.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
156
154
10.39
139.57
1.9
1.4
pmol/l
16.4
14.8
1.46
140
131
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3223
22719
1.96
130.38
8.7
5.6
umol/l
10.2
10.6
1.95
3088
21451
(3044640) Blood type and Crossmatch panel - Blood
2247
14035
1.99
129.44
3.2
2.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3303
23676
1.94
124.83
8.2
5.9
e9/l
0.2
0.2
0.10
2952
20926
(42870588) Differential panel, method unspecified - Blood
2327
14856
1.96
124.50
8.0
5.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
3205
22787
1.93
123.66
7.8
5.7
e9/l
0.6
0.6
0.77
2837
19777
(3032080) INR in Blood by Coagulation assay
2396
15525
1.94
121.97
9.8
6.8
inr
1.2
1.2
0.37
778
4636
(3006315) Basophils [#/volume] in Blood
3206
22876
1.92
121.46
7.8
5.7
e9/l
0.0
0.0
0.16
2837
19823
(3019198) Lymphocytes [#/volume] in Blood
3270
23512
1.92
120.70
7.8
5.7
e9/l
1.9
1.9
0.92
2938
20850
(3022096) Basophils/100 leukocytes in Blood
2951
20582
1.90
118.98
8.1
5.9
%
0.7
0.7
0.75
2799
19134
(3006504) Eosinophils/100 leukocytes in Blood
3008
21280
1.87
114.24
8.1
5.9
%
2.8
2.8
0.14
2845
19756
(3019069) Monocytes/100 leukocytes in Blood
3020
21401
1.87
113.99
8.3
6.1
%
8.5
8.3
2.29
2871
20012
(3002030) Lymphocytes/100 leukocytes in Blood
3087
22071
1.87
112.83
8.1
5.9
%
28.4
29.1
3.41
2933
20522
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
851
3863
2.41
108.74
1.3
1.2
iu/ml
188.2
158.2
1.01
371
1517
(3020779) Urea [Moles/volume] in Serum or Plasma
670
2731
2.65
107.49
12.4
6.2
mmol/l
8.7
8.4
0.71
644
2612
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2995
21411
1.84
107.44
5.0
3.7
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
147
190
7.91
106.67
1.9
1.7
mmol/24h
6.1
6.3
0.04
13
14
(3033658) Prothrombin time (PT) actual/Normal
1773
10782
1.93
105.64
5.4
3.4
%
94.0
94.4
0.26
1733
10499
(3018010) Neutrophils/100 leukocytes in Blood
3023
21784
1.82
104.54
7.9
5.7
%
56.8
56.5
0.80
2872
20338
(3021589) Normoblasts [#/volume] in Blood
2872
20400
1.82
103.94
13.1
8.5
e9/l
0.0
0.0
0.67
2380
16647
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
775
3454
2.44
102.78
6.6
3.0
mmol/l
1.2
1.2
26.39
704
2972
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1001
5004
2.21
101.42
3.1
2.2
%
22.5
23.1
0.66
853
4303
(3022948) Iron [Moles/volume] in Serum or Plasma
1145
6034
2.12
101.41
3.0
2.1
umol/l
13.2
13.8
1.66
1067
5594
(3013707) Erythrocyte sedimentation rate by Westergren method
4317
34997
1.96
100.01
5.0
3.9
mm/h
12.4
11.2
6.61
4088
32521
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1056
5460
2.15
97.93
3.0
2.1
g/l
2.4
2.4
0.72
988
5053
(3026782) Osmolality of Urine
1355
7682
2.00
97.89
3.4
2.4
mosm/kgh2o
530.9
536.6
0.43
1185
6465
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2926
21173
1.78
96.94
3.6
2.7
ug/l
120.3
99.9
4.53
2724
19764
(3002032) Base excess in Venous blood by calculation
679
2928
2.50
96.41
6.1
3.4
mmol/l
2.1
2.0
0.23
557
2368
(3012544) pH of Venous blood
693
3049
2.45
94.10
6.0
3.4
ph
7.4
7.4
—
8
15
(3014576) Chloride [Moles/volume] in Serum or Plasma
882
4337
2.22
92.39
9.9
6.2
mmol/l
104.4
104.6
0.90
864
4258
(3021447) Carbon dioxide [Partial pressure] in Venous blood
672
2951
2.45
91.50
6.1
3.4
kpa
5.9
5.8
0.94
651
2864
(3019550) Sodium [Moles/volume] in Serum or Plasma
5382
48236
3.03
87.78
22.5
11.9
mmol/l
139.7
139.8
2.21
5296
46949
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2170
14705
1.77
87.37
4.0
3.0
u/l
30.9
31.8
0.31
2079
13956
(3044889) 12 lead EKG panel
3941
31611
1.80
86.94
4.3
3.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2200
14986
1.76
86.85
4.9
3.2
e6/l
79.5
97.6
0.74
1595
10182
(3002582) Erythrocytes [#/volume] in Urine
1889
12312
1.80
86.76
4.2
2.8
e6/l
28.9
81.2
3.56
1486
9239
(3003396) Base excess in Arterial blood by calculation
792
3822
2.24
86.47
8.0
6.6
mmol/l
1.0
1.1
0.13
640
2971
(3023103) Potassium [Moles/volume] in Serum or Plasma
5389
48422
3.03
85.70
23.0
12.0
mmol/l
3.9
3.9
7.95
5295
47011
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
808
3958
2.21
84.94
2.1
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
789
3840
2.22
84.23
8.0
6.6
kpa
12.8
12.9
0.26
756
3661
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
789
3841
2.22
84.18
8.0
6.6
kpa
5.2
5.1
0.92
756
3666
(3023368) Bacteria identified in Blood by Culture
1584
9862
1.84
84.15
6.0
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1768
11388
1.80
83.91
4.1
2.7
e6/l
0.3
0.4
2.31
1371
8446
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
808
3979
2.20
83.76
2.2
1.6
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
57
21
27.41
83.73
6.6
1.5
pmol/l
148.4
1.0
—
29
5
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1649
10415
1.82
83.47
2.5
2.1
mg/l
3.0
2.9
0.74
1430
8938
(40758558) Short blood count panel - Blood
1785
11547
1.79
83.40
10.0
6.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4687
39921
1.97
82.48
25.0
13.8
%
13.7
13.6
3.44
4615
39018
(3010375) cycloSPORINE [Mass/volume] in Blood
116
158
7.47
80.42
39.5
24.2
ug/l
139.7
122.5
1.44
103
134
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1583
9989
1.81
79.72
3.6
2.6
ng/l
1189.6
1016.1
0.75
1370
8378
(3011985) Renin [Units/volume] in Plasma
197
449
4.51
79.38
2.6
1.4
mu/l
51.0
54.2
0.13
177
401
(3000991) Gas panel - Venous blood
613
2747
2.38
79.27
10.8
7.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
705
3363
2.25
78.74
8.6
7.0
%
95.9
96.0
0.15
678
3241
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1071
6003
1.97
77.84
2.3
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1810
12045
1.74
74.97
2.5
1.9
u/l
171.0
189.8
0.48
1720
11303
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1001
5563
1.97
74.24
3.2
2.1
s
29.9
29.5
1.42
981
5387
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1291
7802
1.85
74.07
3.5
2.8
mmol/l
2.4
2.4
12.35
1138
6841
(36304419) Bacteria [Presence] in Urine
1712
11267
1.74
73.48
4.1
2.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
676
3281
2.20
72.02
3.3
2.8
g/l
9.9
10.6
4.45
621
3031
(3002173) Hemoglobin [Mass/volume] in Arterial blood
657
3154
2.22
71.91
8.8
7.2
g/l
120.0
121.5
1.05
628
3034
(3000850) Epithelial cells [#/volume] in Urine
1381
8613
1.80
71.00
3.2
2.3
e6/l
5.6
6.8
2.47
1224
7459
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
769
3989
2.07
68.78
8.0
4.2
u/l
235.2
239.8
0.39
733
3787
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1619
10650
1.73
68.73
2.9
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
752
3871
2.09
68.66
4.6
2.6
%
1.8
1.7
0.84
681
3459
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
424
1729
2.57
66.90
10.0
9.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2350
17162
1.63
66.09
2.1
1.8
pmol/l
96.3
98.5
1.44
1271
8615
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1950
13663
1.65
64.28
2.9
2.3
u/l
57.1
58.1
0.31
1817
12566
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
570
2701
2.23
64.09
2.0
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1466
9534
1.72
64.09
1.6
1.4
g/l
2.2
2.3
0.35
943
5836
(3035637) Corticotropin [Mass/volume] in Plasma
190
496
3.93
63.92
2.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3840
31767
1.64
63.22
5.3
4.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
871
4887
1.92
61.83
6.3
2.5
umol/l
6.3
7.1
0.90
771
4172
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1179
7298
1.78
60.93
4.2
3.0
ng/l
252.4
387.2
1.06
854
5008
(3014111) Lactate [Moles/volume] in Serum or Plasma
599
2952
2.15
60.93
9.3
6.1
mmol/l
1.3
1.3
0.57
581
2857
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5234
47545
2.22
60.58
20.6
11.3
mg/l
20.4
21.3
1.45
4422
36621
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
146
326
4.57
60.35
3.5
2.2
nmol/l
19.8
19.8
0.02
137
313
(3026008) Bacteria identified in Urine by Culture
1891
13317
1.63
60.15
3.4
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1041
6247
1.82
59.58
3.7
2.5
e6/l
3.1
3.5
0.58
548
3252
(3017446) Testosterone [Moles/volume] in Serum or Plasma
430
1867
2.41
59.14
3.7
2.0
nmol/l
11.9
12.2
0.25
390
1661
(3028026) IgM [Mass/volume] in Serum or Plasma
529
2511
2.22
59.05
2.0
1.9
g/l
1.3
1.4
0.28
491
2320
(3031040) Bacteria [#/volume] in Urine by Automated count
3677
30375
1.59
58.21
5.5
4.0
e6/l
452.3
2198.1
3.61
66
335
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
236
764
3.18
57.13
13.3
4.8
iu/ml
523.6
403.2
0.26
45
85
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
701
3761
1.98
56.42
2.6
2.2
g/l
0.2
0.2
1.36
663
3550
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1109
6880
1.76
56.36
3.5
2.4
e6/l
1.0
1.7
0.91
609
3859
(3009508) Creatinine [Moles/volume] in Urine
1733
12125
1.62
55.66
3.4
3.0
mmol/l
6.8
7.3
5.17
1514
10192
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1495
10088
1.65
55.52
2.5
1.7
mg/l
1.3
1.0
0.83
1163
7594
(3004119) Hemoglobin [Mass/volume] in Venous blood
432
1933
2.34
55.41
5.1
2.8
g/l
128.5
130.0
0.67
416
1888
(3042936) Bacteria identified in Isolate by Culture
951
5681
1.81
54.82
2.3
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1564
10767
1.62
53.21
3.6
2.2
umol/l
4034.4
3925.9
0.04
1390
9366
(3020682) Albumin/Creatinine [Ratio] in Urine
1644
11467
1.61
52.95
4.2
3.7
mg/mmol
12.4
6.7
2.84
1032
6772
(3012516) Albumin [Mass/volume] in Urine
1584
10950
1.62
52.93
3.5
3.0
mg/l
699.5
382.8
1.22
990
6409
(3035350) Ketones [Presence] in Urine by Test strip
2850
22534
1.53
52.31
4.3
3.4
estimate
0.0
0.0
1.08
609
4142
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2056
15140
1.56
52.27
3.9
2.9
ng/l
183.7
78.5
0.31
1303
8932
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1609
11247
1.60
50.99
1.4
1.3
u/ml
1.6
1.4
0.28
460
3132
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
190
581
3.35
50.47
5.2
2.7
u/ml
130.9
1486.9
—
8
35
(3023520) Reticulocytes [#/volume] in Blood
552
2830
2.05
50.18
3.5
2.6
e9/l
71.1
69.2
0.54
410
2086
(3021601) Nitrite [Presence] in Urine by Test strip
2851
22696
1.51
49.63
5.9
4.6
estimate
0.0
0.0
0.80
622
4218
(3009261) Glucose [Presence] in Urine by Test strip
2872
22920
1.51
49.25
4.3
3.5
estimate
0.0
0.0
0.35
609
4163
(3027273) Bicarbonate [Moles/volume] in Venous blood
348
1493
2.42
48.98
4.3
2.6
mmol/l
25.9
25.5
1.43
335
1448
(3021960) Folate [Moles/volume] in Serum or Plasma
1361
9264
1.62
47.61
1.6
1.5
nmol/l
20.8
21.1
0.20
1209
7926
(3012565) Volume of 24 hour Urine
93
174
5.42
47.27
2.5
2.2
ml
1951.8
1964.9
0.04
82
157
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
354
1557
2.36
47.09
7.5
4.0
mmol/l
24.4
24.3
0.32
323
1391
(3024354) Oxygen [Partial pressure] in Venous blood
494
2493
2.07
46.76
5.7
3.0
kpa
4.6
4.6
0.07
477
2415
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
377
1720
2.28
46.04
10.8
8.4
mmol/l
24.5
24.4
0.38
355
1608
(40760892) CBC W Ordered Manual Differential panel - Blood
1515
10675
1.57
45.41
5.3
4.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
46
40
11.59
44.69
3.7
1.9
pmol/l
55.4
54.9
0.01
39
33
(4035726)
701
4045
1.84
44.60
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5368
50100
2.20
44.21
18.5
10.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
161
484
3.39
43.95
2.3
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
546
2930
1.95
43.39
3.3
2.4
g/l
66.0
66.9
1.85
513
2678
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
150
435
3.51
43.30
1.4
1.3
pmol/l
318.1
287.4
0.44
126
335
(40768804) Tissue Pathology biopsy report
2557
20266
1.47
43.21
2.3
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
712
4168
1.81
43.13
3.9
2.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
440
2190
2.09
43.12
4.9
4.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
426
2104
2.11
42.60
7.1
6.6
mmol/l
24.8
24.7
0.25
395
1949
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4904
44588
1.71
42.23
18.7
10.2
ml/min/173m2
83.6
84.3
1.36
4313
36511
(1616796) Gas panel - Central venous blood
207
739
2.87
42.18
3.7
3.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
163
509
3.27
41.88
1.8
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
309
1350
2.36
41.68
4.9
4.9
%
1.7
1.6
0.49
290
1262
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
320
1421
2.33
41.58
2.0
1.7
g/l
1.5
1.5
0.15
282
1214
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
141
404
3.55
41.47
2.6
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
98
215
4.62
41.45
2.4
2.7
%
37.2
43.3
0.97
23
73
(3037522) Nuclear Ab [Titer] in Serum
1031
6774
1.64
40.83
1.4
1.4
titre
481.7
571.0
0.85
214
1470
(3007853) Bacteria identified in Skin by Aerobe culture
811
5004
1.72
40.79
1.9
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
240
950
2.59
40.04
5.9
4.1
mg/l
1.4
1.4
1.03
226
880
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
171
565
3.09
39.99
1.8
1.2
nmol/l
0.4
0.4
0.03
12
24
(3024932) HLA-DR beta [Type]
68
111
6.19
39.86
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
187
653
2.93
39.68
2.6
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
516
2800
1.93
39.55
4.0
2.5
ng/l
181.4
153.4
0.63
471
2524
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
224
864
2.66
39.37
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4698
42438
1.61
39.27
6.3
4.8
mmol/mol
39.8
38.5
18.65
4441
39364
(3024471) HLA-A [Type]
68
113
6.08
39.16
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
457
2387
1.99
39.14
3.2
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1068
7145
1.61
39.12
1.9
1.7
nmol/l
1208.1
1180.8
0.42
851
5440
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
245
991
2.54
39.08
1.4
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
257
1065
2.48
38.95
4.9
5.7
mmol/l
1.2
1.2
0.17
223
923
(3036603) Volume of Urine
96
219
4.44
38.70
1.7
1.4
ml
1908.8
1978.8
0.15
19
43
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
231
921
2.57
37.97
2.5
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
299
1349
2.28
37.41
5.0
4.9
%
0.9
0.9
0.08
280
1258
(3015235) Bicarbonate [Moles/volume] in Capillary blood
207
788
2.69
37.34
4.0
2.7
mmol/l
25.0
25.0
0.06
184
686
(3012501) Base excess in Blood by calculation
208
795
2.68
37.23
4.1
3.4
mmol/l
2.6
2.5
0.27
153
529
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
227
908
2.56
37.06
2.6
1.6
—
—
—
0
0
(3010421) pH of Blood
235
956
2.52
37.04
4.0
3.2
ph
7.4
7.4
0.01
204
784
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
207
797
2.66
36.52
1.6
1.3
u/ml
112.8
114.0
0.06
41
178
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1604
11914
1.48
35.96
1.8
1.6
mmol/l
1.4
1.3
3.76
1385
10000
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5390
50837
2.08
35.80
14.9
9.3
u/l
25.9
25.1
2.72
5290
49053
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
146
470
3.16
35.71
4.1
3.1
nmol/l
3.9
16.4
0.55
140
459
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
661
3991
1.74
35.64
2.7
2.2
u/l
43.4
49.9
0.20
582
3404
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
417
2179
1.99
35.60
4.9
3.4
kpa
5.2
5.2
0.05
393
2022
(3009343) pH of Capillary blood
411
2147
1.99
35.11
5.0
3.4
ph
7.4
7.4
0.08
76
283
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
401
2077
2.00
35.09
4.9
3.3
mmol/l
2.1
1.8
0.95
295
1550
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
286
1306
2.25
34.75
2.9
2.3
%
92.3
94.1
0.56
268
1211
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
229
950
2.47
34.62
4.6
3.0
ratio
4.9
1.5
0.45
21
90
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
234
985
2.43
34.28
4.5
3.1
mg/l
33.5
42.6
0.65
190
798
(3034860) Kappa light chains.free [Mass/volume] in Serum
234
987
2.43
34.12
4.5
3.1
mg/l
49.5
52.2
0.11
189
797
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
210
852
2.52
33.30
1.4
1.2
u/ml
311.2
267.7
1.10
140
530
(40760888) Immunoglobulin light chains.free panel - Serum
188
724
2.65
33.17
4.2
3.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
41
47
8.78
32.76
2.9
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
218
907
2.46
32.76
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
927
6232
1.58
32.67
1.3
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
196
781
2.56
32.27
5.4
3.5
kpa
8.4
8.6
0.44
185
725
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
120
365
3.34
32.23
1.3
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
261
1184
2.26
32.22
4.0
2.7
g/l
3.4
3.6
1.28
252
1119
(21494815) CD4 cells/100 lymphocytes in Specimen
117
351
3.38
32.11
2.9
2.3
%
35.4
44.2
1.09
13
48
(3036489) Thrombin time
313
1538
2.10
31.60
2.7
2.1
s
21.4
21.0
0.69
279
1314
(3003181) Sodium [Moles/volume] in Urine
123
385
3.24
31.55
1.5
1.3
mmol/l
61.3
69.3
1.29
108
299
(3021901) Oxygen saturation in Capillary blood
156
563
2.82
31.21
3.6
2.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
102
286
3.61
31.06
2.9
2.8
e6/l
664.1
783.6
0.68
25
127
(3008536) Aspergillus sp Ab [Presence] in Serum
51
81
6.34
30.73
4.2
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
153
551
2.83
30.73
3.8
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
259
1200
2.21
30.37
3.4
2.6
%
189.3
180.2
0.87
250
1143
(3009214) Lutropin [Units/volume] in Serum or Plasma
271
1282
2.17
30.18
2.0
1.3
u/l
13.9
12.5
0.64
219
1057
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
291
1416
2.11
30.14
1.6
1.8
g/l
0.2
0.2
1.62
272
1345
(3039000) Anion gap in Blood
184
736
2.55
30.07
5.8
6.9
mmol/l
11.3
11.0
0.69
165
653
(3009445) Proteinase 3 Ab [Units/volume] in Serum
330
1684
2.02
30.06
1.7
1.5
u/ml
9.5
14.4
—
10
41
(3018572) Chloride [Moles/volume] in Blood
184
737
2.55
29.98
5.8
6.9
mmol/l
105.6
105.6
0.10
165
654
(40767503) Oxygen content in Capillary blood by calculation
183
732
2.55
29.91
2.8
2.1
%
16.5
16.5
0.05
99
361
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4923
45632
1.57
29.63
4.9
4.1
mmol/l
5.9
5.8
9.30
4616
41908
(3007566) Smooth muscle Ab [Titer] in Serum
258
1206
2.19
29.60
1.2
1.3
titre
118.3
153.5
0.20
23
109
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
150
546
2.79
29.54
1.2
1.1
g/l
1.1
1.5
11.27
130
494
(3026250) Tacrolimus [Mass/volume] in Blood
64
131
4.93
29.48
36.8
33.4
ug/l
7.4
7.4
0.05
57
119
(3016244) Insulin [Units/volume] in Serum or Plasma
101
293
3.49
29.23
3.0
3.5
mu/l
17.4
29.0
2.31
96
280
(40768797) Stomach Pathology biopsy report
917
6297
1.54
29.12
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
351
1852
1.95
29.05
1.9
2.0
u/l
39.2
40.0
0.31
313
1686
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
223
989
2.31
29.04
4.8
3.0
u/ml
0.3
0.4
1.49
125
549
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3631
31866
1.38
28.89
3.6
2.8
u/l
48.0
40.6
4.41
3436
29905
(3000570) Elastase.pancreatic [Mass/mass] in Stool
259
1225
2.17
28.85
1.4
1.4
ug/g
287.3
295.5
0.24
152
684
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
42
58
7.29
28.80
1.2
1.1
pmol/l
2.1
6.8
—
5
6
(3052851) Hemolysis interference index of Serum or Plasma
251
1178
2.18
28.51
3.8
2.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
189
789
2.44
28.22
1.8
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
101
301
3.40
28.05
1.6
1.5
mosm/kgh2o
281.8
284.9
0.72
78
225
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
292
1463
2.05
27.97
1.6
1.7
g/l
1.2
1.2
1.22
272
1392
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
75
183
4.14
27.79
1.8
1.5
nmol/l
4.3
5.8
0.20
62
140
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
664
4283
1.62
27.49
3.6
4.0
ug/l
78.2
20.2
0.57
515
3341
(44790048)
128
449
2.89
27.02
2.7
1.5
—
—
—
0
0
(44790049)
128
449
2.89
27.02
2.7
1.5
—
—
—
0
0
(44806118)
128
449
2.89
27.02
2.7
1.5
—
—
—
0
0
(44790047)
128
449
2.89
27.02
2.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
166
671
2.52
26.57
2.5
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
289
1473
2.01
26.40
5.0
2.5
%
0.6
0.7
0.62
277
1402
(3048929) Epstein Barr virus Ab [Presence] in Serum
286
1453
2.02
26.36
1.3
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
23
15
15.39
26.23
3.1
3.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
26
22
11.87
25.60
1.8
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1591
12440
1.39
25.05
4.1
3.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
126
460
2.78
24.73
1.3
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
245
1204
2.08
24.73
1.3
1.3
titre
448.0
832.5
—
5
52
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1222
9148
1.43
24.71
1.7
1.6
pmol/l
36540767.4
34513602.0
0.05
1029
7713
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
121
434
2.83
24.55
8.5
6.1
mg/l
11.5
11.1
0.40
110
400
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
22
15
14.72
24.49
3.2
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
163
681
2.43
24.33
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1373
10518
1.40
24.28
4.0
3.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
171
734
2.37
24.04
2.0
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
265
1354
2.00
24.04
1.8
1.6
titre
516.4
314.9
0.37
11
74
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
130
490
2.69
24.01
2.6
2.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
530
3342
1.65
23.90
4.5
4.3
%
0.0
0.4
1.16
143
751
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
205
956
2.19
23.69
1.5
1.4
e6/l
49.9
25.6
0.42
155
754
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
205
957
2.18
23.63
1.6
1.5
e6/l
263.3
1358.8
2.17
165
792
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
352
2000
1.81
23.11
1.1
1.1
u/ml
1.3
2.2
—
5
25
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
159
677
2.39
22.78
2.0
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
166
721
2.34
22.74
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2132
17646
1.33
22.67
4.6
3.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
181
817
2.26
22.66
2.4
2.1
g/l
129.4
130.5
0.22
137
576
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
83
251
3.34
22.60
1.5
1.4
umol/l
4.2
4.7
0.63
77
233
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
197
924
2.17
22.45
3.5
3.7
%
56.1
57.0
0.43
197
924
(3024980) IgG subclass 4 [Mass/volume] in Serum
166
727
2.32
22.32
1.9
1.6
g/l
0.7
0.7
0.04
116
550
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
230
1149
2.04
22.22
3.1
2.9
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
42
76
5.56
22.22
1.6
1.3
mu/l
88.7
52.6
0.52
33
61
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
238
1204
2.02
22.21
1.9
2.1
mg/l
10.6
10.8
0.17
224
1127
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
160
691
2.35
22.21
1.7
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
259
1350
1.96
22.20
3.1
3.5
u/ml
291.8
1308.7
0.71
227
1141
(40761536) Microorganisms panel - Urine sediment
597
3962
1.57
21.69
4.8
3.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
322
1818
1.82
21.58
2.3
1.6
mu/l
319.0
299.3
0.48
297
1624
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
197
941
2.13
21.45
3.2
2.1
g/l
0.0
0.0
0.00
189
879
(3023183) Ammonium ion [Moles/volume] in Plasma
146
615
2.41
21.45
2.7
2.6
umol/l
32.1
34.9
0.81
121
536
(3017143) Hepatitis C virus Ab [Presence] in Serum
776
5461
1.49
21.42
1.8
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
151
648
2.37
21.28
6.3
3.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
557
3660
1.58
21.11
4.7
4.2
%
1.0
0.8
0.51
160
932
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
198
954
2.11
21.08
3.2
2.1
g/l
0.0
0.0
0.50
189
882
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
241
1250
1.97
20.97
3.5
2.1
g/l
9.9
10.3
0.72
212
1062
(3009542) Hematocrit [Volume Fraction] of Blood
4740
44261
1.42
20.91
23.1
12.2
%
39.3
39.8
3.26
3516
33466
(3001964) Herpes simplex virus Ag [Presence] in Specimen
55
132
4.20
20.90
2.7
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
511
3302
1.60
20.78
3.3
3.4
u/ml
36.3
51.2
1.06
494
3187
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
254
1346
1.93
20.75
3.4
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
354
2080
1.75
20.72
1.9
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
254
1347
1.93
20.71
3.5
2.1
g/l
7.4
7.3
0.23
206
1031
(3028192) IgG subclass 2 [Mass/volume] in Serum
118
457
2.62
20.70
1.7
1.3
g/l
2.9
3.0
0.10
80
316
(3024139) IgG subclass 3 [Mass/volume] in Serum
118
457
2.62
20.70
1.7
1.3
g/l
0.3
0.4
1.23
79
312
(3021440) Promyelocytes/100 leukocytes in Blood
536
3512
1.58
20.55
4.6
4.2
%
0.1
0.1
0.45
152
864
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
67
188
3.59
20.49
1.5
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
67
188
3.59
20.49
1.5
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
745
5244
1.48
20.49
1.8
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
5537
53619
2.10
20.47
30.7
16.9
pg
30.1
30.2
3.16
5490
52900
(3024731) MCV [Entitic volume]
5537
53621
2.09
20.43
30.8
16.9
fl
90.6
90.8
1.38
5490
52903
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
129
525
2.49
20.43
2.1
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
253
1346
1.92
20.43
3.5
2.1
g/l
3.8
3.7
0.36
201
976
(3010813) Leukocytes [#/volume] in Blood
5538
53639
2.10
20.35
30.9
17.0
e9/l
6.6
6.6
1.41
5440
52176
(3026361) Erythrocytes [#/volume] in Blood
5537
53629
2.09
20.29
30.9
17.0
e12/l
4.5
4.5
0.47
5442
52190
(3027135) IgG subclass 1 [Mass/volume] in Serum
117
458
2.59
20.10
1.7
1.3
g/l
6.6
6.7
0.14
78
316
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
242
1277
1.93
20.03
3.4
2.1
g/l
3.0
3.1
0.50
203
1004
(3007461) Platelets [#/volume] in Blood
5532
53585
2.06
19.92
30.9
17.0
e9/l
260.1
259.6
0.26
5447
52268
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
171
796
2.18
19.90
2.0
1.6
nmol/l
43.7
42.8
0.14
166
777
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
205
1023
2.04
19.89
3.3
2.0
g/l
0.0
0.0
0.22
196
947
(3000963) Hemoglobin [Mass/volume] in Blood
5536
53644
2.07
19.81
31.1
17.1
g/l
133.7
134.7
6.15
5489
52921
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
46
100
4.63
19.81
1.5
1.5
ug/l
0.4
0.4
0.10
26
65
(4062490)
115
450
2.59
19.78
1.8
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
516
3381
1.58
19.76
4.3
4.0
%
0.8
0.5
1.31
125
697
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
220
1131
1.98
19.65
2.8
2.1
ug/l
207.7
618.1
1.41
205
1041
(3005322) IgE [Units/volume] in Serum or Plasma
491
3201
1.58
19.20
1.5
1.3
u/ml
166.9
193.5
0.46
460
2982
(3029937) Albumin [Presence] in Urine by Test strip
1513
12139
1.34
19.18
4.8
3.8
estimate
0.0
0.0
2.12
607
4165
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
127
529
2.43
19.16
2.2
1.7
pmol/l
178.7
199.7
1.07
117
497
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
54
137
3.97
19.08
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
150
675
2.26
18.97
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
208
1068
1.98
18.66
3.3
2.0
g/l
37.7
38.2
0.57
193
925
(3044290) Cell count panel - Cerebral spinal fluid
184
904
2.07
18.64
1.6
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
655
4577
1.49
18.58
22.9
20.2
inr
1.2
1.2
0.58
88
705
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
91
327
2.81
18.50
2.7
2.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
111
442
2.54
18.44
3.3
2.5
e9/l
1.3
1.2
0.38
72
267
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
220
1158
1.94
18.36
3.6
2.1
g/l
0.9
0.9
0.01
203
1010
(3020961) Endomysium IgA Ab [Titer] in Serum
393
2454
1.65
18.33
1.1
1.1
titre
53.5
195.1
—
10
66
(3014148) Varicella zoster virus Ab [Titer] in Serum
142
634
2.27
18.31
1.2
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
20
19
10.56
18.21
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
20
19
10.56
18.21
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
20
19
10.56
18.21
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
155
720
2.18
18.16
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
37
72
5.17
18.13
2.1
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1166
9063
1.36
18.08
1.3
1.3
iu/ml
26.1
32.8
0.73
367
2895
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
55
148
3.74
17.92
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
43
97
4.46
17.72
4.0
4.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
189
960
2.00
17.50
1.4
1.3
mmol/l
3.7
3.6
0.39
178
901
(3022145) Colonoscopy Study observation
715
5150
1.44
17.29
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
87
318
2.76
17.16
3.3
2.7
e6/l
580.9
515.4
0.63
69
264
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
208
1101
1.92
17.09
1.5
1.3
mg/l
489.8
492.2
0.03
196
1049
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
35
69
5.10
16.91
1.6
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
183
935
1.99
16.68
1.7
1.4
nmol/l
0.3
0.4
1.25
143
718
(3021879) Hepatitis B virus core Ab [Presence] in Serum
527
3601
1.51
16.61
1.6
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
100
399
2.53
16.59
1.9
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1108
8646
1.35
16.58
1.3
1.3
u/ml
9.0
11.8
0.77
424
3587
(3048689) Calprotectin [Mass/mass] in Stool
834
6225
1.40
16.45
2.3
2.3
ug/g
120.9
116.5
0.16
673
4876
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
345
2143
1.65
16.42
1.6
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
84
310
2.74
16.28
3.4
2.8
e9/l
0.2
0.2
0.19
69
262
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
436
2873
1.56
16.23
2.3
2.1
ug/l
8.1
6.5
0.68
374
2504
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5013
47697
1.42
16.16
5.3
4.3
mmol/l
2.8
2.9
11.35
4735
44115
(3017817) Protein [Mass] in Urine collected for unspecified duration
76
267
2.87
16.15
2.9
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1597
13163
1.30
16.12
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
154
755
2.07
15.75
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
154
755
2.07
15.75
1.4
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
471
3180
1.52
15.70
1.8
1.3
iu/l
30.2
30.1
0.03
387
2767
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
46
120
3.86
15.69
2.3
2.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
91
357
2.57
15.65
2.8
2.1
%
13.0
13.9
0.23
57
177
(3015171) Extractable nuclear Ab [Units/volume] in Serum
330
2056
1.64
15.53
1.3
1.3
u/ml
0.4
1.2
1.71
32
189
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
108
462
2.36
15.44
1.2
1.2
u/l
76.8
55.3
1.57
91
303
(3022313) Gas panel - Capillary blood
268
1584
1.73
15.38
5.6
3.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
77
280
2.77
15.37
2.8
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
569
4015
1.46
15.26
1.2
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
18
19
9.50
15.21
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
477
3252
1.51
15.17
2.5
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
221
1240
1.81
15.17
2.4
2.0
ug/l
2.3
1.9
0.20
199
1107
(3030981) Hyaline casts [#/volume] in Urine by Automated count
308
1899
1.66
15.10
3.3
2.2
e6/l
0.3
0.3
0.17
303
1826
(21494434) Karyotype in Bone marrow
79
297
2.68
14.81
1.2
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
18
20
9.03
14.65
1.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
405
2687
1.55
14.62
1.3
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
50
146
3.45
14.50
2.7
2.5
e6/l
211.3
141.0
0.52
30
80
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4742
44880
1.33
14.41
4.2
3.5
mmol/l
1.3
1.2
21.22
4454
41378
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
74
274
2.72
14.30
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4409
41329
1.29
14.28
26.8
14.5
g/l
331.7
331.9
0.92
4381
41024
(3023419) Bacteria identified in Sputum by Culture
105
460
2.31
14.25
3.3
2.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
73
269
2.74
14.24
1.7
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
101
439
2.32
13.96
1.8
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
200
1119
1.82
13.88
2.2
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
46
131
3.53
13.87
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
52
161
3.25
13.77
2.4
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
103
457
2.28
13.59
2.4
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4923
46963
1.35
13.32
4.8
3.9
mmol/l
4.7
4.9
14.90
4654
43733
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
142
720
2.00
13.30
2.0
2.0
nmol/l
0.8
0.8
0.43
123
621
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
86
357
2.43
13.20
1.3
1.1
—
—
—
0
0
(3000492) Spirometry study
616
4530
1.40
13.11
1.7
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
102
460
2.24
12.96
1.6
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
69
260
2.67
12.93
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
56
190
2.97
12.75
1.7
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
130
649
2.03
12.73
1.6
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3586
33006
1.23
12.51
3.4
3.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
111
528
2.12
12.38
1.7
1.5
iu/ml
28.1
22.2
—
7
25
(40757373) Influenza virus identified in Isolate
28
60
4.68
12.33
2.5
1.5
—
—
—
0
0
(3013512) EKG study
1449
12134
1.26
12.23
4.1
3.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
64
239
2.70
12.23
6.5
2.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
45
138
3.28
12.14
16.6
3.4
mg/l
63.5
1525.9
0.50
40
100
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
92
412
2.25
11.93
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4884
46678
1.32
11.92
4.7
3.9
mmol/l
1.5
1.5
18.25
4600
43295
(3006653) Thiamine [Moles/volume] in Blood
56
199
2.83
11.76
1.3
1.3
nmol/l
129.7
133.2
0.28
56
199
(3037121) Protein [Mass/volume] in Urine
220
1329
1.68
11.72
3.4
3.1
g/l
0.3
0.3
0.06
113
501
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
91
412
2.23
11.51
2.6
1.7
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
41
123
3.35
11.47
4.5
2.9
ng/l
109.1
149.3
0.31
25
53
(21494890) Protein electrophoresis panel - 24 hour Urine
74
307
2.43
11.43
2.7
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
76
320
2.39
11.37
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
49
4.91
11.19
6.4
5.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
102
489
2.11
11.19
1.4
1.2
—
—
—
0
0
(4010399)
447
3194
1.43
11.16
1.7
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
80
348
2.32
11.13
1.2
1.3
titre
73.1
224.1
2.70
13
76
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
72
299
2.43
11.11
1.3
1.4
nmol/l
1.3
1.4
0.42
66
266
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
194
1150
1.71
11.10
1.2
1.3
u/ml
33.2
40.3
0.29
21
127
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
481
3507
1.41
10.72
2.9
2.4
ml/min/173m2
62.5
70.3
4.11
206
1299
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
106
525
2.04
10.68
1.3
1.2
u/l
85.4
34.7
1.01
97
458
(3051611) Lipemic interference index of Serum or Plasma
88
407
2.18
10.60
5.7
2.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
23
48
4.81
10.47
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
112
574
1.97
10.27
1.7
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
60
238
2.54
10.23
2.3
2.2
%
102.4
100.4
0.14
55
221
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
64
263
2.45
10.13
1.0
1.1
nmol/l
3.8
12.4
0.63
13
51
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
136
747
1.84
10.13
2.9
2.4
ug/min
63.5
73.4
0.19
95
427
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
99
488
2.05
10.13
1.8
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
20
38
5.28
10.10
3.9
3.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
137
755
1.83
10.09
2.0
1.4
ug/l
2.0
3.7
3.46
102
659
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
123
655
1.90
10.09
1.2
1.1
%
119.8
118.2
0.20
104
596
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
949
7710
1.28
10.08
1.7
1.6
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
19
35
5.44
9.91
2.4
2.8
mg/l
1.2
1.8
0.25
12
23
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
240
1547
1.58
9.90
1.9
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
226
1439
1.59
9.82
5.8
3.6
mmol/l
25.0
24.9
0.09
215
1346
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1202
10067
1.25
9.82
1.6
1.6
—
—
—
0
0
(3020891) Body temperature
225
1434
1.59
9.74
6.2
4.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
67
290
2.33
9.49
1.7
1.5
u/l
5.4
5.6
0.03
39
133
(3027456) Digoxin [Moles/volume] in Serum or Plasma
111
587
1.91
9.33
4.0
3.1
nmol/l
0.8
0.8
0.84
91
446
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
125
687
1.84
9.32
1.3
1.2
u/ml
3.5
3.8
0.07
38
227
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
31
89
3.50
9.32
1.3
1.2
pmol/l
617.0
282.1
1.09
20
68
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
20
41
4.89
9.30
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
37
121
3.07
9.07
1.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
59
247
2.40
9.02
7.7
3.5
%
10.5
11.4
0.72
59
247
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
50
194
2.59
8.96
1.9
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
218
1408
1.57
8.95
1.1
1.1
u/ml
4.5
6.3
0.37
25
189
(4281824)
113
611
1.87
8.89
1.2
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
213
2.50
8.85
1.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
49
190
2.59
8.80
1.9
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
82
398
2.08
8.80
1.4
1.3
titre
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
227
1489
1.55
8.71
1.3
1.3
u/ml
29.5
40.9
0.32
14
107
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
79
381
2.09
8.63
1.3
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
70
324
2.17
8.50
1.3
1.2
—
—
—
0
0
(4306422)
121
680
1.80
8.43
1.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
26
71
3.67
8.43
1.2
1.9
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
59
255
2.33
8.43
1.5
1.4
u/l
5.5
5.6
0.02
42
216
(3044927) Protein electrophoresis panel - Urine
71
333
2.15
8.34
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
119
669
1.80
8.29
1.3
1.2
u/ml
5.2
3.8
0.48
50
281
(3020876) Protein [Mass/time] in 24 hour Urine
62
276
2.26
8.28
2.3
1.9
—
1.8
—
0
20
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
74
355
2.10
8.21
1.4
1.3
u/ml
1.3
1.1
0.09
36
156
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
17
34
5.01
8.13
13.9
7.8
mmol/l
5.2
6.0
0.53
17
34
(3042631) Mycobacterium sp identified in Specimen
92
480
1.93
8.10
2.6
2.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
155
945
1.66
8.09
1.6
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
67
312
2.16
8.03
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
148
897
1.67
7.91
4.4
4.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1145
9740
1.22
7.88
4.6
3.9
kg/l
1.0
1.0
0.30
182
1404
(40768795) Lymph node Pathology biopsy report
89
466
1.92
7.78
1.4
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
40
150
2.68
7.71
1.2
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
71
3.53
7.68
1.7
1.3
ng/l
79.2
103.0
0.44
25
71
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
76
379
2.02
7.64
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
76
379
2.02
7.64
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
244
1673
1.48
7.63
1.7
1.8
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
116
665
1.76
7.60
1.2
1.3
u/ml
63.2
54.3
—
5
49
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
76
380
2.01
7.58
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
58
261
2.23
7.58
1.7
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
75
376
2.01
7.44
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
75
376
2.01
7.44
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
75
377
2.00
7.39
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
455
3490
1.33
7.38
2.4
2.4
au/ml
19.3
24.3
0.54
23
230
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
49
209
2.36
7.26
1.1
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
11
7
15.75
7.22
1.2
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
31
105
2.96
7.21
7.9
3.8
%
52.6
52.5
0.01
31
100
(3004809) Band form neutrophils/100 leukocytes in Blood
108
617
1.76
7.19
5.2
3.3
%
1.4
1.4
0.05
93
493
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
39
150
2.61
7.18
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1074
9154
1.21
7.18
1.9
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
118
692
1.72
7.17
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
37
139
2.67
7.13
2.8
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
229
1573
1.47
7.12
1.7
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
166
1065
1.58
7.09
5.3
3.8
mmol/l
3.8
3.8
0.50
153
1013
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
32
113
2.84
6.93
3.9
1.6
ug/l
2.7
2.0
0.45
26
58
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
418
3199
1.33
6.90
1.3
1.3
au/ml
51.7
48.1
0.08
12
146
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
221
2.27
6.85
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
200
1350
1.50
6.80
1.2
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
108
628
1.73
6.78
1.1
1.1
iu/ml
65.1
14246.3
0.56
26
170
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
69
348
1.99
6.77
2.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
69
348
1.99
6.77
2.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
69
348
1.99
6.77
2.4
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
214
1466
1.48
6.77
1.3
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
201
1360
1.50
6.76
1.3
1.3
u/ml
26.6
6.4
0.72
23
239
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
87
475
1.84
6.75
1.2
1.1
%
95.3
95.2
0.02
79
452
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
199
1345
1.50
6.73
1.3
1.3
u/ml
3.5
4.9
0.21
16
144
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
106
615
1.74
6.71
1.9
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
43
180
2.40
6.67
1.2
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
52
237
2.21
6.64
1.1
1.1
u/ml
1.8
20.3
—
5
24
(3014765) Yersinia sp identified in Stool by Organism specific culture
198
1344
1.49
6.56
1.2
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
17
41
4.16
6.54
4.7
7.1
ug/min
26.5
42.6
0.57
11
28
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
58
278
2.10
6.54
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
46
201
2.30
6.49
1.3
1.6
—
—
—
0
0
(4212803)
16
37
4.33
6.48
1.2
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
66
333
1.99
6.48
1.1
1.0
mg/l
309.6
290.4
0.61
60
305
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
58
280
2.08
6.42
1.1
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
39
159
2.46
6.41
2.0
2.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
80
433
1.86
6.40
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
175
1168
1.51
6.31
2.7
2.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
21
61
3.45
6.27
1.2
1.1
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
9
5
18.02
6.26
2.2
2.0
%
8.4
6.4
—
9
5
(3019977) pH of Arterial blood
40
169
2.38
6.11
3.0
3.0
ph
7.4
7.4
1.02
20
68
(3026389) Candida sp identified in Specimen by Organism specific culture
119
732
1.64
6.10
1.5
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
72
383
1.89
6.09
4.0
3.9
mmol/l
6.9
6.9
0.02
63
316
(3006922) Hepatitis E virus Ab [Presence] in Serum
61
307
2.00
6.06
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
56
274
2.05
6.01
1.2
1.1
u/l
1.0
1.1
1.07
18
117
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
194
1337
1.47
5.99
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
179
1214
1.49
5.99
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
36
147
2.46
5.93
3.7
4.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
36
4.18
5.81
1.5
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
42
187
2.26
5.72
2.4
2.2
min
496.8
495.2
0.04
36
140
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
298
2235
1.35
5.68
2.8
2.1
u/l
5154.8
4723.1
0.08
104
877
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
50
240
2.09
5.66
1.6
1.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
17
46
3.70
5.63
1.1
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
28
104
2.70
5.58
1.1
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
28
104
2.70
5.58
1.1
1.2
%
97.6
96.9
0.05
28
104
(3013336) Amino acids [Identifier] in Serum or Plasma
9
7
12.87
5.57
1.9
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
63
331
1.91
5.56
3.5
4.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
40
178
2.26
5.47
1.7
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
54
271
2.00
5.45
1.6
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
27
100
2.71
5.42
1.5
1.3
umol/l
16.0
17.6
1.47
27
86
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
48
233
2.07
5.30
1.6
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
65
356
1.84
5.09
2.5
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
457
5611
0.80
5.01
4.7
4.0
%
32.5
32.7
0.17
338
3843
(3044941) Cell count panel - Synovial fluid
102
637
1.61
5.00
1.7
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
64
351
1.83
5.00
1.6
1.4
e6/l
1462.8
2811.0
1.62
47
255
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
45
219
2.06
4.96
1.1
1.0
%
99.1
90.0
1.19
32
169
(4027681)
56
295
1.91
4.95
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
101
631
1.61
4.95
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
61
331
1.85
4.93
1.4
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
61
3.12
4.90
2.6
1.4
—
—
—
0
0
(1002224) Polysomnography panel
262
1974
1.34
4.89
1.1
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
21
72
2.92
4.86
1.0
1.1
umol/24h
118.9
0.7
—
6
36
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
56
297
1.89
4.86
1.2
1.1
ratio
1.1
1.0
1.04
21
103
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
51
262
1.96
4.86
1.7
1.5
u/ml
26.3
19.9
0.48
12
54
(4268621)
79
466
1.71
4.83
2.4
2.3
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
33
143
2.32
4.83
1.2
1.5
mu/l
489.0
439.0
0.17
33
138
(3027923) C peptide [Moles/volume] in Serum or Plasma
40
189
2.12
4.77
1.8
1.5
nmol/l
1.1
1.3
0.68
33
150
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
37
170
2.18
4.73
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
40
190
2.11
4.71
1.2
1.2
g/l
0.3
0.3
0.70
33
157
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
157
1092
1.45
4.71
1.2
1.3
u/ml
1.0
2.5
—
10
82
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
294
2267
1.31
4.69
2.4
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
271
2068
1.33
4.65
1.2
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
24
91
2.64
4.64
4.5
4.8
u/l
32.8
85.0
—
6
32
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
58
3.11
4.63
6.1
7.9
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
29
4.14
4.62
1.4
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
263
2003
1.33
4.58
3.6
3.1
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
33
147
2.25
4.55
1.2
1.5
%
70.7
72.3
0.19
33
142
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
98
2.56
4.54
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
31
135
2.30
4.51
2.5
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
33
148
2.24
4.49
3.2
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
70
2.86
4.48
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
33
149
2.22
4.42
1.3
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
39
189
2.07
4.39
1.2
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
60
337
1.79
4.38
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
31
137
2.27
4.37
1.0
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
45
231
1.96
4.33
1.1
1.1
u/l
57.5
18.9
0.46
26
177
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
45
231
1.96
4.33
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
76
459
1.66
4.30
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
47
247
1.91
4.24
1.2
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
45
233
1.94
4.24
1.1
1.1
u/l
113.3
77.2
0.53
31
184
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
59
334
1.77
4.21
1.2
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
34
159
2.15
4.20
1.2
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
16
51
3.14
4.20
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
451
5437
0.81
4.18
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
31
140
2.22
4.17
3.2
2.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
33
153
2.16
4.17
7.5
3.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
143
1004
1.44
4.13
1.3
1.2
—
—
—
0
0
(3025315) Body weight
10
23
4.35
4.08
5.9
3.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
47
251
1.88
4.05
2.6
2.2
ml
624.2
641.7
0.12
39
171
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
63
2.86
4.05
6.1
7.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
49
266
1.85
4.02
1.4
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
362
1.72
4.00
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
410
3364
1.24
3.98
1.3
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
9
14
6.44
3.98
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
57
330
1.73
3.81
3.2
2.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
113
772
1.47
3.79
1.7
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
112
765
1.47
3.77
1.1
1.1
u/ml
3.4
3.5
0.05
59
373
(3008757) Leukocyte morphology finding [Identifier] in Blood
70
430
1.64
3.76
5.9
4.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
35
175
2.01
3.67
1.1
1.2
%
115.4
111.2
0.44
30
161
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
8
12
6.67
3.67
1.9
2.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
196
1482
1.33
3.66
1.6
1.6
iu/ml
0.1
4.6
0.53
53
282
(43055514) Macroprolactin [Presence] in Serum or Plasma
26
116
2.25
3.63
1.1
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
65
396
1.65
3.62
1.5
1.4
g/l
32.1
33.8
0.45
58
360
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
79
506
1.57
3.60
1.1
1.1
—
4.3
—
0
7
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
119
831
1.44
3.59
2.8
3.4
u/ml
1310.8
712.8
0.30
111
758
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
17
62
2.75
3.58
1.4
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
54
314
1.73
3.57
1.6
1.4
e6/l
28095.9
69916.8
0.86
32
182
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
64
390
1.65
3.57
1.3
1.2
mg/l
40.8
35.0
0.38
53
328
(3012441) Differential panel - Pleural fluid
51
292
1.75
3.56
1.5
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
18
68
2.65
3.55
1.6
1.2
—
—
—
0
0
(4094501)
151
1105
1.38
3.50
1.1
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
36
3.34
3.47
1.3
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
21
87
2.42
3.46
1.7
2.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
33
166
1.99
3.43
2.7
2.2
mmol/l
9.0
9.4
0.38
24
130
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
55
326
1.69
3.42
1.7
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
17
64
2.66
3.39
3.6
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
32
160
2.01
3.38
3.5
2.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
34
175
1.95
3.32
2.9
1.9
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
23
102
2.26
3.28
1.2
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
76
494
1.55
3.28
1.9
1.6
—
1086.7
—
0
12
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
43
241
1.79
3.25
1.3
1.4
titre
80.0
565.9
—
7
17
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
733
6455
1.16
3.25
4.7
4.5
ug/l
1.9
2.5
1.89
655
5795
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
9
19
4.74
3.23
1.1
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
213
1.84
3.21
3.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
213
1.84
3.21
3.1
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
213
1.84
3.21
3.1
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
35
185
1.90
3.18
1.8
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
35
185
1.90
3.18
1.8
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
214
1.83
3.17
3.1
1.8
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
15
55
2.73
3.15
7.3
2.1
mmol/l
0.7
1.5
—
10
40
(1761868) Lipid panel - Serum or Plasma
1913
17881
1.11
3.14
3.0
2.5
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
13
44
2.96
3.13
3.0
2.0
umol/l
1.3
1.4
0.55
13
36
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
14
50
2.80
3.08
3.0
2.4
—
—
—
0
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
10
29
3.45
3.04
1.5
1.7
mg/l
1.0
1.3
—
5
18
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
29
3.45
3.04
1.4
1.9
umol/l
59.3
46.1
—
10
29
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
178
1370
1.31
3.00
1.2
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
20
87
2.30
3.00
1.3
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
24
113
2.13
2.99
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
120
2.09
2.97
1.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
18
75
2.40
2.96
1.6
2.4
mmol/l
7.4
6.8
0.17
11
38
(3028433) Virus identified in Specimen by Culture
29
148
1.96
2.94
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
121
885
1.38
2.88
1.7
1.7
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
12
41
2.93
2.85
3.8
7.0
g/mol
33.0
73.1
0.73
12
35
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
69
455
1.52
2.84
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
59
376
1.58
2.82
1.2
1.1
mg/l
211.7
229.5
0.51
50
327
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
8
18
4.45
2.79
1.6
1.1
nmol/l
497.6
300.1
—
8
18
(3019225) pH of Specimen
505
4379
1.17
2.77
8.2
3.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
97
689
1.41
2.75
2.4
2.2
umol/l
6.4
6.6
0.04
79
499
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
424
4938
0.85
2.75
1.6
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
23
111
2.08
2.72
1.3
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
19
85
2.24
2.70
1.2
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
63
413
1.53
2.68
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
24
119
2.02
2.65
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
50
312
1.61
2.63
1.6
1.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
13
49
2.66
2.62
1.5
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
60
392
1.54
2.60
4.2
3.4
%
58.8
55.7
0.51
44
270
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
15
4.67
2.59
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
613
5420
1.15
2.59
1.6
1.7
%
1.4
1.4
0.26
552
4847
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
209
1680
1.25
2.55
2.5
1.9
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
11
5.46
2.54
1.0
1.0
%
3.3
2.5
—
6
11
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
220
2701
0.81
2.52
1.4
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
31
172
1.81
2.49
2.0
2.5
umol/l
178.3
163.6
0.08
17
92
(3006270) Folate [Moles/volume] in Blood
55
357
1.55
2.47
1.1
1.1
nmol/l
409.2
382.4
0.41
43
321
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
7
16
4.38
2.47
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
190
1521
1.26
2.42
2.0
1.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
34
2.94
2.41
1.4
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
26
138
1.89
2.40
3.3
2.4
—
—
—
0
0
(3013762) Body weight Measured
6
12
5.00
2.40
1.2
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
12
5.00
2.40
4.0
1.8
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
6
12
5.00
2.40
3.0
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
131
1.91
2.40
5.2
3.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
45
282
1.60
2.36
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
67
962
0.69
2.36
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
183
2272
0.80
2.35
1.5
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
57
378
1.51
2.34
1.3
1.4
mmol/l
12.2
12.0
0.07
27
70
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
80
568
1.41
2.33
1.8
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
48
307
1.57
2.32
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
16
72
2.23
2.27
1.7
1.4
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
13
4.62
2.27
1.0
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
18
3.89
2.25
6.6
11.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
37
224
1.66
2.23
1.2
1.1
miu/ml
1583.6
1490.7
0.20
37
224
(3004716) Salmonella sp identified in Stool by Organism specific culture
307
2610
1.19
2.19
1.4
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
42
2.62
2.18
5.7
8.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
182
1471
1.25
2.17
1.5
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
77
553
1.40
2.13
1.9
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
55
2.37
2.12
1.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30
175
1.72
2.09
3.5
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30
175
1.72
2.09
3.5
1.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
27
153
1.77
2.07
1.3
1.1
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
5
10
5.00
2.07
1.2
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
31
2.91
2.07
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
129
1007
1.29
2.07
1.8
1.6
e6/l
7722.7
10332.9
0.58
95
742
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
628
5650
1.13
2.07
1.7
1.8
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
20
3.50
2.05
1.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
20
3.50
2.05
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
50
334
1.50
2.03
2.3
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
30
177
1.70
2.01
3.5
1.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
26
3.08
2.01
1.5
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
27
155
1.75
1.99
1.1
1.1
%
90.6
94.8
0.32
18
69
(40761535) Cells panel - Urine sediment
400
3505
1.15
1.98
4.1
3.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
115
891
1.30
1.97
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
76
554
1.38
1.95
1.8
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
27
2.97
1.93
1.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
16
3.75
1.93
5.8
7.1
—
—
—
0
0
(4034850)
185
1520
1.22
1.93
9.8
8.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
11
45
2.45
1.92
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
101
1311
0.77
1.92
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
76
556
1.37
1.92
1.8
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
232
1951
1.20
1.91
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
29
173
1.68
1.89
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
42
275
1.53
1.89
1.1
1.4
promille
1.1
1.2
0.37
36
214
(3005988) Vibrio sp identified in Specimen by Organism specific culture
76
558
1.37
1.88
1.8
1.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
52
2.31
1.87
1.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
11
46
2.39
1.85
2.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
25
144
1.74
1.84
1.2
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
40
2.50
1.83
1.7
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
76
561
1.36
1.83
1.9
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
42
278
1.51
1.81
1.6
1.5
ug/l
12.6
7.5
0.41
37
242
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
35
2.57
1.80
2.7
3.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
23
3.05
1.80
7.0
6.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
213
1791
1.20
1.78
1.4
1.3
miu/ml
219.5
230.8
0.18
99
892
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
316
2748
1.16
1.76
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
26
154
1.69
1.75
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
88
1.93
1.74
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
88
1.93
1.74
1.4
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
88
1.93
1.74
1.4
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
338
2966
1.15
1.68
3.4
2.8
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
31
2.58
1.65
1.1
1.1
u/l
7.9
17.3
—
8
31
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
26
157
1.66
1.65
1.1
1.1
%
85.2
91.5
0.66
17
69
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
304
0.56
1.64
1.2
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
50
351
1.43
1.64
1.1
1.1
iu/ml
11.3
10.4
0.07
17
92
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
14
3.57
1.61
1.2
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
14
3.57
1.61
3.8
3.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
8
32
2.50
1.59
1.1
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
382
3397
1.13
1.57
2.6
2.6
e9/l
4.3
4.0
1.71
310
2741
(44816559) Phosphatidylethanol [Mass/volume] in Blood
103
814
1.27
1.57
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
567
5161
1.11
1.56
4.0
4.0
%
23.8
21.5
2.42
258
2429
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
43
611
0.70
1.54
1.2
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
31
200
1.55
1.53
1.4
1.6
iu/ml
—
1213233.1
—
0
13
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
7
27
2.59
1.51
11.9
4.4
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
6
21
2.86
1.50
2.0
1.5
—
0.0
—
0
6
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
86
1.86
1.50
4.6
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
86
1.86
1.50
4.6
2.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
15
79
1.90
1.49
1.5
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
13
65
2.00
1.48
1.0
1.3
—
—
—
0
0
(4024509)
31
465
0.66
1.48
1.7
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
48
342
1.41
1.48
3.3
2.5
mg/l
38.9
35.3
0.05
37
236
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
87
1.84
1.45
1.1
1.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
9
38
2.37
1.45
2.7
3.1
mg/l
22.5
21.9
—
9
38
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
16
3.13
1.44
1.8
2.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
12
59
2.04
1.43
1.1
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
80
621
1.29
1.43
1.2
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
39
2.31
1.43
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
95
1.79
1.42
5.2
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
27
173
1.56
1.39
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
222
1921
1.16
1.38
1.7
1.7
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
17
96
1.77
1.38
1.2
1.1
%
78.5
81.9
—
8
20
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
30
198
1.52
1.37
1.3
1.4
pmol/l
114.2
241.5
0.34
18
55
(4038314)
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
112
1.70
1.35
2.4
1.3
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
37
0.00
1.34
0.0
1.0
—
6.4
—
0
29
(3036071) Salmonella sp Ab [Titer] in Serum
26
167
1.56
1.34
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
18
105
1.72
1.33
1.3
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
29
192
1.51
1.31
6.0
4.6
u/ml
3067.8
178.1
—
6
31
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
17
98
1.74
1.30
1.2
1.1
%
66.9
74.8
—
9
20
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
103
836
1.24
1.30
1.5
1.8
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
6
24
2.50
1.30
2.7
1.7
%
36.7
59.5
—
6
14
(3019174) dRVVT (LA screen)
9
43
2.09
1.30
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
12
62
1.94
1.27
1.1
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
302
3385
0.89
1.27
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
40
285
1.41
1.27
4.7
1.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
19
2.63
1.21
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
122
1455
0.83
1.19
1.3
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
111
920
1.21
1.17
3.3
3.2
mg/l
26.4
25.2
0.12
70
546
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
575
6205
0.92
1.17
2.0
2.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
25
165
1.52
1.17
1.3
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
57
1.93
1.17
1.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
14
79
1.77
1.16
1.3
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
122
1451
0.84
1.16
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
123
1458
0.84
1.14
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
123
1457
0.84
1.13
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
105
870
1.21
1.13
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
155
1797
0.86
1.10
1.3
1.4
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
7
32
2.19
1.08
1.1
1.3
%
76.5
68.6
—
7
25
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
26
178
1.46
1.05
1.0
1.1
ng/l
130.2
306.4
—
6
36
(3002523) Influenza virus A Ag [Presence] in Specimen
104
869
1.20
1.04
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
22
2.27
1.03
1.6
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
134
1561
0.86
1.03
1.4
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
514
5526
0.92
0.99
1.9
1.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
17
261
0.65
0.98
8.6
12.3
nmol/l
514.8
859.1
2.22
17
249
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
415
3824
1.09
0.97
1.7
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
587
5487
1.08
0.97
1.5
1.4
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
0.7
—
0
16
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
17
260
0.65
0.97
2.4
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
36
1.95
0.97
1.1
1.1
umol/24h
53.2
1.6
—
7
36
(3032057) Clostridioides difficile [Presence] in Stool
12
69
1.74
0.96
2.1
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
182
1.43
0.95
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
40
302
1.33
0.95
1.2
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
9
51
1.77
0.94
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
42
320
1.31
0.94
1.3
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
27
2.22
0.93
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
27
2.22
0.93
1.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
17
109
1.56
0.93
1.8
1.4
%
36.2
39.8
—
9
71
(40761995) Spermatozoa Progressive [#/volume] in Semen
12
70
1.72
0.92
2.0
2.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
12
70
1.72
0.92
4.0
5.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
52
1.73
0.92
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
96
1133
0.84
0.90
1.6
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
18
266
0.68
0.89
10.5
17.7
nmol/l
930.9
5019.6
0.60
18
258
(44813793)
47
368
1.28
0.88
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
64
523
1.23
0.84
1.6
1.7
%
49.7
53.7
0.25
34
323
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
104
1.54
0.84
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
74
615
1.21
0.83
1.3
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
354
0.73
0.82
1.3
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
23
163
1.41
0.81
1.3
1.2
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
12
73
1.65
0.81
1.7
1.4
g/l
23.9
28.8
—
7
59
(3044007) Cell count panel - Peritoneal fluid
15
97
1.55
0.81
2.6
1.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
107
1235
0.86
0.79
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1118
10747
1.05
0.77
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
323
2988
1.09
0.74
1.6
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
104
1195
0.87
0.73
1.3
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
55
1.64
0.73
1.2
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
30
228
1.32
0.72
2.2
1.7
u/field
2.2
3.8
0.72
22
156
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
90
774
1.17
0.72
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
60
1.67
0.72
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
104
1192
0.87
0.71
1.3
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
26
1.92
0.70
1.4
2.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
58
1.55
0.69
1.1
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
14
93
1.51
0.69
1.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
42
1.67
0.68
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
43
1.63
0.66
2.0
1.9
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
28
1.79
0.66
3.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
125
1111
1.13
0.65
1.5
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
95
1.47
0.64
2.9
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
250
2307
1.09
0.64
1.5
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
26
198
1.31
0.64
1.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
16
112
1.43
0.63
1.8
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
30
1.67
0.61
2.8
1.8
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
21.8
—
0
21
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
36
1.67
0.56
2.2
2.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
213
1967
1.09
0.56
1.9
1.7
mg/l
5.8
3.9
1.01
164
1364
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
25
319
0.78
0.56
1.1
1.1
—
—
—
0
0
(44806071)
10
65
1.54
0.55
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
38
461
0.82
0.55
1.6
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
79
693
1.14
0.53
1.3
1.3
mmol/l
7.4
7.2
0.29
59
523
(4198724)
24
187
1.28
0.52
1.7
2.9
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
6
40
1.50
0.51
1.0
1.1
—
3.5
—
0
6
(3042517) Benzodiazepines panel - Urine
6
41
1.46
0.50
2.0
2.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
47
400
1.18
0.48
1.5
1.5
%
47.2
34.8
0.96
24
239
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
49
1.43
0.46
2.9
2.5
—
—
—
0
0
(4015189)
14
104
1.35
0.43
2.3
2.6
—
—
—
0
0
(4146454)
40
340
1.18
0.43
3.0
2.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
239
1.21
0.42
1.0
1.0
ng/l
766.6
746.9
0.08
21
153
(3047007) Chlamydophila sp Ab [Presence] in Serum
85
764
1.11
0.42
1.3
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
46
532
0.86
0.42
1.7
2.1
mg/l
32.4
22.8
0.61
13
143
(3013293) Extractable nuclear Ab [Presence] in Serum
6
91
0.66
0.42
1.8
1.7
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.2
—
2.3
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
57
1.40
0.42
1.1
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
57
1.40
0.42
5.1
7.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
58
1.38
0.41
3.6
5.9
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.0
—
5.0
—
0
8
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
59
1.36
0.41
6.5
3.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
155
1440
1.08
0.40
1.3
1.3
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
7
101
0.69
0.39
1.1
1.0
u/ml
0.1
7.4
—
7
75
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
90
816
1.10
0.39
1.3
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
270
0.81
0.39
1.7
1.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
41
354
1.16
0.38
1.0
1.1
u/ml
1.7
2.3
0.15
22
101
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
243
1.19
0.37
1.0
1.0
ng/l
35.3
48.6
1.02
21
157
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
152
1.25
0.37
2.1
2.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
26
311
0.84
0.36
1.4
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
42
1.43
0.35
2.2
2.2
u/field
0.7
0.6
—
6
42
(3024263) Appearance of Synovial fluid
25
208
1.20
0.35
1.4
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
85
775
1.10
0.35
1.5
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
42
367
1.15
0.34
1.1
1.2
—
5.6
—
0
26
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
105
970
1.08
0.33
1.6
1.4
u/l
29.9
28.4
0.15
90
801
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
118
1096
1.08
0.33
1.1
1.1
u/ml
1.6
1.3
0.08
54
428
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
28
238
1.18
0.32
1.0
1.0
ng/l
288.7
353.3
0.46
21
159
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
23
193
1.19
0.30
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
99
0.71
0.30
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
395
3813
1.04
0.30
2.8
2.9
ug/l
0.7
0.7
1.59
266
2437
(3023511) Choriogonadotropin [Units/volume] in Urine
124
1161
1.07
0.29
1.3
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
94
1.28
0.28
1.8
2.1
umol/l
10.9
15.8
1.49
12
94
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
27
233
1.16
0.27
1.6
2.9
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
8
65
1.23
0.27
1.8
1.4
—
150.4
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
111
1040
1.07
0.26
1.9
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
374
0.88
0.26
1.2
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
32
361
0.89
0.24
1.1
1.1
u/ml
1.6
1.5
0.05
15
89
(3016879) Cocaine [Presence] in Urine
163
1711
0.95
0.24
1.7
2.2
—
—
—
0
0
(3001729) Color of Synovial fluid
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
97
1.24
0.22
1.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
97
1.24
0.22
2.6
1.6
e6/l
31084.0
22873.8
—
5
56
(3020650) Glucose [Presence] in Urine
16
134
1.19
0.22
1.3
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
105
990
1.06
0.22
1.0
1.1
u/ml
3.7
5.0
0.57
62
519
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
91
0.77
0.22
1.4
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
98
925
1.06
0.21
1.1
1.1
u/ml
1.8
2.0
0.05
27
221
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
14
117
1.20
0.20
1.1
1.1
u/ml
87.6
53.4
0.64
14
111
(44806420)
10
80
1.25
0.20
2.1
2.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
35
316
1.11
0.20
1.9
1.8
mmol/l
7.1
6.4
0.53
29
214
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
12.5
—
0
9
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
170
1771
0.96
0.20
1.9
1.9
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
12
144
0.83
0.19
2.1
3.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
70
746
0.94
0.19
1.1
1.1
u/ml
2.5
3.6
0.51
29
296
(3008401) Mugwort IgE Ab [Units/volume] in Serum
100
949
1.05
0.18
1.0
1.1
u/ml
1.0
1.1
0.02
45
409
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
53
1.13
0.18
8.2
3.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
53
1.13
0.18
1.7
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
12
143
0.84
0.18
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
181
1876
0.96
0.18
1.6
2.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
69
0.72
0.16
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
48
515
0.93
0.16
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
181
1871
0.97
0.16
1.6
2.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
63
669
0.94
0.16
1.1
1.1
u/ml
2.1
0.3
0.42
16
148
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
36
332
1.08
0.15
2.9
2.1
u/field
3.2
2.3
0.36
13
135
(3038026) Centromere Ab [Units/volume] in Serum
43
400
1.08
0.15
1.2
1.2
—
49.0
—
0
27
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
121
1.16
0.15
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
38
410
0.93
0.15
1.5
1.6
mmol/l
7.7
7.6
0.10
24
260
(3010144) Erythrocytes [#/volume] in Synovial fluid
42
391
1.07
0.14
1.5
1.4
e6/l
47124.7
47930.8
0.01
28
273
(3028707) Methadone [Presence] in Urine by Screen method
83
794
1.05
0.13
1.9
3.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
138
1426
0.97
0.13
1.8
2.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
123
1.14
0.12
1.1
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
180
1844
0.98
0.11
1.6
2.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
55
526
1.05
0.09
4.6
5.3
umol/l
340.9
372.4
1.01
47
456
(3012494) Peanut IgE Ab [Units/volume] in Serum
17
155
1.10
0.09
1.1
1.1
u/ml
0.5
1.6
1.09
12
83
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
54
1.11
0.09
1.2
1.3
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
6
55
1.09
0.08
1.0
1.1
mmol/l
19.0
20.4
—
6
47
(3000764) Benzodiazepines [Presence] in Urine
182
1856
0.98
0.08
1.6
2.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
65
1.08
0.08
1.1
1.4
%
13.7
27.4
—
7
51
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
551
5457
1.01
0.08
7.6
5.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
78
803
0.97
0.07
1.2
1.1
u/ml
5.1
3.3
0.41
31
301
(3045414) Leukocytes [Presence] in Urine
214
2108
1.02
0.07
1.8
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
24
226
1.06
0.06
1.1
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
31
325
0.95
0.06
1.1
1.0
u/ml
0.2
1.9
—
7
45
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
119
1.09
0.06
1.3
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
123
1253
0.98
0.06
2.0
3.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
17
159
1.07
0.05
1.6
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
15
140
1.07
0.04
1.3
1.6
ug/l
9.6
8.1
0.67
15
140
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
37
358
1.03
0.04
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
13
121
1.07
0.03
1.1
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
102
1.08
0.03
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
102
1.08
0.03
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
102
1.08
0.03
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
102
1.08
0.03
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
122
1.07
0.02
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
13
122
1.07
0.02
1.0
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
122
1.07
0.02
1.1
1.0
—
—
—
0
0
(4211845)
25
243
1.03
0.01
3.3
3.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
507
5062
1.00
0.00
1.6
1.7
—
—
—
0
0
(4133840)
12
122
0.98
0.00
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
26
258
1.01
0.00
1.3
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
14
135
1.04
0.00
10.7
11.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
114
0.96
0.00
1.1
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
12
117
1.03
0.00
1.3
1.2
g/l
38.1
38.5
—
7
66
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.1
—
0.2
—
0
8
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
66.1
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
76
0.92
0.00
1.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
84
0.95
0.00
1.5
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
22
220
1.00
0.00
2.4
3.4
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
93
0.97
0.00
1.4
1.4
%
36.8
23.6
—
9
83
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
40.1
—
0
5
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_METABO – Other metabolic disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).